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Prologue   
 
In the beginning there were stem cells. This is how every story of organogenesis start. 
Chondrogenesis is one of the most unique amongst them involving extremely fascinating 
characters and stages of development. Condensation of mesenchymal stem cells with 
epithelial cells, commitment to the lineage, formation of chondrocytes which in turn generate 
cartilage specific extracellular matrix (ECM); then the cells attain prehypertrophic stage 
which leads to hypertrophy and in the end a phoenix like death of chondrocytes giving way to 
the birth of bone, and the life goes on.  
This thesis deals with one small part of the chondrogenesis story, i.e. the beginning. It probes 
the biological factors which may have an influence on induction and maintenance of 
chondrogenesis in vitro. The rationale for this and other similar studies lies in the 
irreparableness of the cartilage tissue. Cartilage does not repair itself neither offers any easy 
way for aided repair. Thus, comes tissue engineering in to the picture. Like every other 
engineering, tissue engineering also needs at first a blue print of the structure to be 
constructed. Construction materials and tools are required and everything has to be done 
efficiently in the most cost effective manner as quickly as possible. For cartilage tissue 
engineering, time limitation is further intense because a human being is suffering while we are 
tinkering in the lab. Joint forces of biomechanics, biomaterials and cell biology provide us 
with the tools. Immense concentrated effort is directed to develop an ideal material to be used 
as anlage, and to attain enough cells to start the in vitro synthesis of cartilage. We are trying 
our best to engineer cartilage tissue as efficiently as possible but our knowledge of the blue 
print is limited and incomplete; we know a lot, still there are mysteries unknown to us. We 
know growth factors like IGF´s, TGF´s and BMP´s help chondrogenesis but we are struggling 
to employ them fruitfully. We have identified some biomaterials like fibrin and have 
constructed many synthetic biosorbable scaffolds but we have still not optimized the use of 
these materials to obtain the desired type of cartilage tissue in vivo. We can isolate 
chondrocytes and embed them in the scaffolds to tip off cartilage construction but the 
chondrocytes tend to become fibroblasts in our labs. We know that mesenchymal stem cells 
(MSCs) are chondroprogenitor cells and that they reside in the bone marrow but we do not 
know sufficiently how their proliferation and differentiation is regulated by the factors from 
their native environment. In short, there are many open issues and a collective effort is called 
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for to provide pain free and agile life for osteoarthritis patients and injured sportsmen. This 
thesis is yet another effort to fill some of the gaps in our collective knowledge of 
chondrogenesis induction and maintenance of the desired phenotype. 
The focus of this study is the regulatory effect of the surrounding environment on 
chondrogenic differentiation of MSCs. We have been able to show that both the bone marrow 
microenvironment and cartilage tissue influence chondrogenesis at different stages. The effect 
itself could be shown at molecular as well as on biochemical level. The involved cell types 
and various paracrine factors were also identified. At the last stage, one of the effected 
molecules, a major transcription factor was knocked down and an experimental study model 
was setup for future studies on chondrogenesis related genes.  
This thesis is structured in a series of four major titles (chapter 2-5), each title is a short 
complete account based on different aspects of chondrogenesis in MSCs. In the sixth and last 
chapter the data presented in the preceding chapters are collectively concluded and analyzed 
in the light of ‘influencing chondrogenesis’. The first chapter is a prelude to the main topic, 
an in depth introduction of the molecules and processes appearing in the following chapters. 
Here, we have discussed articular cartilage and related molecules and the physiological 
process of chondrogenesis. The importance of MSCs pertaining chondrogenesis is also in 
detail explored along with the bone marrow microenvironment. MSCs are the main tools of 
this study therefore; in the second chapter MSCs are investigated in depth. Here we establish 
osteo-chondro progenitor status of MSCs by doing osteogenic and chondrogenic 
differentiation studies. The genes and proteins which may predestine MSCs to become 
committed chondroprogenitor cells are screened by quantitative PCR (qPCR) and antibody 
microarray. Thus, this chapter constitutes a foundation on which the next chapters are 
constructed. The third chapter deals specifically with chondrogenesis of MSCs in 3-D high 
density alginate cultures in vitro. MSCs source of origin, native environment and in vitro 
behaviour is explored with immunofluorescence and FACS. With the help of MACS and 
qPCR we demonstrate how the other cells of bone marrow microenvironment influence 
chondrogenesis.  In the fourth chapter effect of cartilage tissue on the differentiating MSCs 
is studied. The behaviour of chondrogenically differentiating MSCs under the influence of 
articular cartilage explants is investigated in a novel coculture model. The differences and the 
putative responsible factors have been identified by qPCR, antibody arrays, zymography, 
immunobloting and collagen preparations. The fourth chapter revealed transcriptional factor 
Sox9 as an effected molecule therefore, in the fifth chapter a method was developed to knock 
down Sox9 by RNA interference. Sox9 is an integral regulator of chondrogenic lineage 
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differentiation therefore, this retroviral based Sox9 gene silencing experimental model system 
can be used to identify direct and indirect role of Sox9 in chondrogenic regulation.  
The methods and identified molecules described in this thesis collectively make up one more 































     Specific questions 
 
• Do undifferentiated multipotent MSCs express osteo-chondro 
lingeage specific genes? 
 
• Does the native bone marrow environment influence 
chondrogenesis in MSCs? 
 
• Does cartilage affect chondrogenic differentiation of MSCs? 
 
• Can we achieve efficient chondrogenesis via biological factors? 
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Chapter 1 
 




Articular cartilage disorders and injuries often end up as life long chronic pain and 
compromised quality of life. When it comes to local articular cartilage defects modern 
medicine is limited to short term pain relief and inflammation control. In extreme cases the 
affected tissue is surgically removed and replaced by synthetic prostheses carrying an expiry 
date. Cell based therapies to regenerate articular cartilage are in use since 1994. Such 
therapies provide a healthy population of cells to the injured site and require differentiated 
chondrocytes from uninjured site as base material. Use of healthy chondrocytes often lead to 
donor side morbidity and generate rigid fibrous cartilage when more flexible hyaline cartilage 
is required. The major restrictive factor for such methods is inadequate number and limited 
proliferation capacity of chondrocytes in vitro. The discovery of adult marrow stromal cells 
/mesenchymal stem cells (MSCs), their unlimited proliferation potential and proven capability 
to differentiate into chondrocytes is therefore significant. However, for optimal harnessing of 
MSCs as chondroprogenitor cells basic background information regarding commitment to the 
lineage, cartilage differentiation and the regulatory factors and molecules is essential. The 
current knowledge of cartilage differentiation has lots of open ends. This review covers the 
latest information regarding cartilage developmental pattern. Though MSCs are no longer 
considered as panacea, still the vision of autologous ex-vivo created hyaline cartilage tissue 
may come true with tissue engineering of MSCs.  
 
Key words: Chondrogenesis, mesenchymal stem cells, articular cartilage, Sox9, bone marrow 
 




Tissue engineering uses living cells, biomatrices and signalling molecules to provide new 
functional tissue hence it combines cell biology, engineering, material sciences and surgery. 
The potential of tissue engineering is endless and ranges from cardiac valve generation to ex-
vivo cartilage construction. Damaged articular cartilage specifically requires tissue 
engineering based therapeutic methods because of its minimal self-repair capacity (Solchaga 
et al., 2004). 
Defects in cartilage structure, biosynthesis, and assembly lead to severe diseases or 
abnormalities such as osteoarthritis, campomelic dysplasias or multiple epiphyseal dysplasia 
etc (Ge et al., 2006; Mansour et al., 1995; Thur et al., 2001). Any defect or external injury 
leading only to chondral lesions (more then 5 mm) is detrimental to normal living because it 
does not spontaneously heal due to the avascular nature of the tissue and, more importantly, 
because of chondroprogenitor cells deficiency. Even if the injury is osteochondral in nature 
and penetrates through the vascularized subchondral bone it usually results into fibrous 
cartilage formation which is quite rigid and lacks the characteristic features of chondrocytes 
derived hyaline matrix. Therapies are usually restricted to surgical intervention as autologous 
osteochondral transfer (OCT), fresh osteochondral allograft and microfracturing. All of the 
surgical methods have limitations and high risk potential to the donor and recipient tissue. 
OCT or mosaicplasty is limited to the damaged area of less then 2 cm2,  lack of compatible 
donor tissue is the major limitation of allogenic osteochondral graft and microfracturing cues 
off fibrocartilage formation (Cancedda et al., 2003). A classical cell based therapeutic option 
in use since 12 years is autologous chondrocyte transfer (ACT). The most important factor for 
this and any other tissue engineering method is the source and origin of the appropriate cells. 
For ACT autologous chondrocytes from healthy tissue of minor weight bearing areas are 
isolated by enzymatic digestion, expanded in culture and then injected at the injured cartilage 
site under a periosteal flap or a synthetic matrix (Brittberg et al., 1994). However, the 
generated tissue is mostly fibrous and rigid and the risk of permanent damage to the donor site 
is too large. Furthermore, differentiated chondrocytes do not proliferate in vitro and attempts 
of induction of proliferation leads to dedifferentiate towards fibroblast like cells.  Thus, the 
need of specific chondroprogenitor cells, with high proliferation capacity in combination with 
good differentiation potential, is evident for regenerative therapy. The discovery of skeletal 
stem cells or MSCs has opened new horizons for bone/cartilage reconstructive procedures 
(Cancedda et al., 2003).  
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1. Cartilage 
Cartilage is an essentially avascular highly specialized connective tissue of mesenchymal 
lineage. It is widely distributed throughout the body and has multiple pre- and post-natal 
functions. In adults the most highly manifested function is in assisting bones to withstand 
compressive forces; in addition it has a vital role in skeletal development and growth. During 
embryogenesis most of the bones, with exception of craniofacial bones are developed by a 
process called “endochondral ossification” in which first a cartilaginous mould is formed 
which is later converted into bone (Goldring et al., 2006).  
Cartilage comprises chondrocytes embedded in self contrived extracellular matrix (ECM). 
Primary molecules of ECM are collagens which constitute 60% of cartilage protein bulk. The 
most dominant (90-95%) form of cartilaginous collagen is collagen type II which forms a 
heterofibrillar structure together with (~5-10%) type XI and type IX collagens (Mendler et al., 
1989). In addition, cartilage ECM also contains large proteoglycans as aggrecan and 
hyaluronic acid and several small leucine rich proteoglycans (SLRPs) e.g. decorin and 
biglycan (Iozzo, 1999). Non-collagenous adhesive glycoproteins as fibronectin, tenascin, 
matrilins and cartilage oligometric protein (COMP) often function as adapter proteins 
connecting fibrillar structures with the extra fibrillar matrix that may contribute to the stability 
and structural integrity of the ECM (Budde et al., 2005).  
On the basis of biochemical composition, morphology and composition of ECM cartilage is 






Fibro cartilage  Elastic cartilage  Hyaline cartilage 
Figure 1: Histological analysis of different cartilage types. The three kinds of cartilage can 
be differentiated by haematoxylin eosin (H&E) staining. Fibrous cartilage shows bundles of 
fibres, elastic cartilage shows elastic fibres. Hyaline cartilage exhibits characteristic ECM 
structures with intermittent chondrocytes in the lacunae. The bar represents 250µm. 
Courtesy of http://www.kumc.edu/instruction/medicine/anatomy/histoweb/cart/cart.htm 
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Hyaline cartilage is the most abundant type of cartilage present in the skeleton of all 
vertebrates. It is mainly found in diarthrodial (synovial) joints forming a smooth surface to 
reduce friction; this hyaline cartilage is termed as articular cartilage. Hyaline cartilage also 
exists inside the bones and forms the growth plate which serves as the template for 
endochondral ossification. Articular cartilage is optically uniform mainly composed of 
chondrocytes and extracellular matrix. It is avascular thus diffusion of nutrients from the 
surrounding diarthrodial fluid is the only means of sustenance. Oxygen tension in articular 
cartilage gets as low as 1-3% compared with 24% in the normal atmosphere (Eikenberry and 
Bruckner, 1999). The more flexible elastic cartilage is mainly found in the pinna of ear and 
lining of the tubes like larynx; it keeps the tubes permanently open. It is similar to hyaline 
cartilage but contains more elastin in the matrix. Fibrous cartilage is tougher and is found in 
the areas which require more tensile strength as intervertebral discs. It contains denser 
collagenous fibrillar network as compared with the hyaline cartilage and lacks perichondrium 
(Eikenberry and Bruckner, 1999) (Fig.1).  
 
ECM turnover by MMPs and Inhibitors 
For stability of functionally competent ECM different proteases and their inhibitors play a 
regulatory role. Among them different matrix metalloproteinases (MMPs) and their inhibitors, 
tissue inhibitors of matrix metalloproteinases (TIMPs) are crucial. MMPs are Ca2+- and Zn2+-
dependent endopeptidases which cleave most of the ECM components. About 25 different 
MMPs have been so far identified and according to the substrate preference have been divided 
into four major classes: collagenases, gelatinases, stromelysins, membrane-type (MT-MMP). 
In contrast, only four TIMPs are known, but they control the activities of all the MMPs. 
TIMPs are significant for tissue development and remodelling. Not well explored hints of 
regulatory activity of TIMPs in cell growth and mesenchymal growth also exist (Mannello et 
al., 2005). Both the MMPs and TIMPs have a large activity portfolio, from ECM regulation to 
embryonic development, morphognesis and cells and tissue development and modulation of 
gene expression. They have also been known to affect cell differentiation (Vu and Werb, 
2000).  
Development of axial and appendicular skeleton during embryogenesis occurs via 
endochondral ossification and depends on chondrocytes fashioned cartilaginous template. 
Ossification begins with chondrocyte hypertrophy and cell death; parallel to severe 
calcification and partial degradation of the template which facilitates vascular invasion, 
essential for skeletogenesis (Haeusler et al., 2005). The remodelling of the cartilaginous 
Ahmed 2006 State of the Art  Chapter 1    
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template is mainly achieved by MMPs employing their proteolytic activity. MMP-13 or 
collagenase-3, a highly expressed collagenolytic MMP detected in primary centre of 
ossification during embryonic development has a critical role in cartilage turnover (Mitchell et 
al., 1996). Absence of MMP-13 hinders hypertrophic differentiation of chondrocytes and 
causes increased length of growth plates and complete distortion in alignment of rows of 
chondrocytes leading to delayed ossification (Inada et al., 2004). Therefore, for normal 
skeletal development and maturation coordinated regulation of the anabolic and catabolic 
ECM associated genes is critical (Von der, 1999). 
 
2. Marrow stromal cells  
All cells arise from a single population of progenitor cells traceable to the fertilized egg or 
zygote, the totipotent embryonic stem cells (ES). In 1970s Friedenstein et al isolated 
pluripotent MSCs with ES properties from adult tissues. The colonogenic adherent cells could 
replicate many folds in culture while retaining their differentiation competence (Friedenstein 




Figure 2: Multilineage potential of MSCs: MSCs have multiple lineage potential to 
differentiate into bone, cartilage, muscle, marrow stroma, tendon/ligament, fat and other 
connective tissues. Each differentiation involves multiple steps controlled by growth factors 
and cytokines. Reproduced from Caplan 2005 (Caplan, 2005).  
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The original discovery was brought in lime light by Pittenger et al in 1999 who showed the 
true promise of MSCs; in their multi-differentiation potential and in the fact that they do not 
harbour ethical questions related with embryonic stem cells research (Pittenger et al., 1999). 
MSCs are a fundamental unit of bone marrow not only as mesenchymal progenitors but also 
as support for haematopoiesis (Bianco et al., 2001). They possess three distinctive 
characteristics of a stem cell; they can be expanded in vitro, they have an unlimited 
proliferation capacity and they can differentiate into multiple lineages namely, osteocytes, 
chondrocytes, adipocytes, astrocytes and myocytes (Fig.2) (Caplan, 2005). The greatest 
importance of MSCs lie in the fact that under specific culture and physical conditions a 
particular differentiation pathway can be induced at will in vitro as well as in vivo (Pittenger 
et al., 1999; Cancedda et al., 2003).  
 
Isolation: 
Initially MSCs were discovered in bone marrow as part of the marrow stroma. It is now 
known that MSCs also exist in umbilical cord blood, teeth, skin, adipose tissue, periosteum, 
trabecular bone and peripheral blood. However, bone marrow still remains the major source 
for MSCs which retain their pluripotency even after 6-10 passages in vitro (Magne et al., 
2005). Iliac crest of pelvis is usually the site of bone marrow extraction in humans and other 
larger animals (Pittenger et al., 1999). In rodents they are easily harvested from mid-diaphysis 
of the tibiae and femora and the marrow extract is directly cultured in tissue culture flasks 
(Maniatopoulos et al., 1988). The bone marrow aspirate from iliac crest is first subjected to 
density gradient centrifugation for separation of mono-nucleated cells and only the MSCs 
fraction is cultured. So method of choice for MSCs isolation mainly depends upon the species 
and source of extraction (Pittenger et al., 1999). Using low seeding density and proper culture 
conditions MSCs can be separated from the other cells of bone marrow due to their adherent 
nature. Distinct colonies of spindle shaped fibroblast like cells termed as colony forming unit-
fibroblast (CFU-F) are major characterization criteria for MSCs (Bianco et al., 2001). Further 
characterization is based on their antigenic profile and differentiation potential. Under proper 
culture conditions and mechanical stimulus MSCs can be induced to differentiate towards 
terminally differentiated cell lineages of mesenchyme in vitro. However most of the MSCs 
populations are heterogenic, comprising of naïve MSCs with multidifferentiation capacity and 
progenitor MSCs which have reached different stages of commitment to a particular lineage. 
Depending on the commitment status these cells exhibit restricted lineage potential (Bianco et 
al., 2001). 
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  7 
Surface markers: 
Not all stromal cells are stem cells however, until to date no unique antigenic cell surface 
marker has been discovered which can positively identify MSCs. Therefore, to characterize 
marrow derived MSCs a consortium of positive and negative markers is required. Stro-1, 
CD29, CD44, CD49a, CD71, CD73, CD90, CD106 are some of the generally accepted 
positive markers (Baksh et al., 2004; Pittenger et al., 1999; Barry, 2003). The consensus is 
that MSCs stain negative for markers of haematopoietic lineage like CD4, CD14, CD34 and 
CD45 (Magne et al., 2005; Baksh et al., 2004). Different techniques like fluorescence 
associated cell sorting (FACS) and magnetic associated cell sorting (MACS) are used to sort 
the cells on the basis of their surface marker profile. Both the techniques are crucial to 
establish the so called “stemness” of the cultured MSCs. An advantage of MACS over FACS 
is that after MACS separation cells can be further cultured and their differentiation and 
proliferation behaviour can be monitored (Majumdar et al., 2000). MACS is routinely used for 
negative selection of bone marrow extracted cells, such cell populations are cultured and 
studied to decipher involvement of  other cells on MSCs proliferation and differentiation in 
vitro.  
 
3. Bone marrow microenvironment in vivo 
The bone cavity of mammalian bone is filled with soft bone marrow (BM) and blood vessels. 
BM is the only organ so far identified which is host of two types of functionally cooperating 
stem cells. The main population of haematopoietic stem cells (HSCs) is supported by bone 
marrow stroma containing a small population of non-blood forming MSCs. In the stroma or 
bone marrow microenvironment, MSCs coexist with endothelial cells, macrophages, 
adipocytes, fibroblasts, osteoprogenitor cells and HSCs and their progeny etc. (Dorshkind, 
1990; Yin and Li, 2006).  
Stem cell niche is where the stem cells reside and undergo self-renewal and/ or differentiation, 
the MSCs niche in the marrow is not well explored. However, existence of two distinct stem 
cell niches has been well argued; an osteoblastic niche for osteoprogenitor cells and a vascular 
niche for HSCs where the mature haematopoietic cells are released into the vascular system 
(Fig 3). Since 1978 HSCs niche has been known and since then the role of their physiological 
microenvironment as structural support and in mediation of cell signalling has been studied in 
depth. MSCs exist in different commitment and differentiation states most likely the so called 
naïve MSCs with true stem cell attribute reside as part of the stroma but the MSCs with 
Chapter 1 State of the art Ahmed 2006 
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committed osteoblastic progenitor status reside in the osteoblastic niche (Moore and 





Figure 3. Bone marrow microenvironment. Bone marrow contains 99% HSCs and <1% 
MSCs. HSCs reside mostly in the osteoblastic niche and move towards the vascular niche at 
the time of differentiation to enter the circulation. Multipotent naïve MSCs are part of the 
stroma however, as the MSCs become committed progenitors they move towards the 
osteoblastic niche. Exact spatial relationships of the bone marrow cells are not well defined 




Both in vivo and in vitro plasticity of MSCs greatly depends on the microenvironment. It has 
been convincingly shown that heterogeneity of the extracted cell population determines their 
differentiation potential. Historically, MSCs as part of BM stroma have been known to 
support haematopoiesis even before their mesodermal progenitor cells status was established 
(Bianco and Robey, 2001). Now it is also known that removal of the native soluble and cell-















Vascular niche Osteoblastic 
niche 
Adipocytes 
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MSCs in vitro. Such discoveries indicate that the signalling cues, cytokines and growth 
factors from the environment are vital for differentiation, proliferation and maintenance of 
differentiation status of HSCs and MSCs (Bianchi et al., 2001). Thus, to provide an optimal 
chondrogenic favourable culture microenvironment in vitro it is necessary to characterize the 
bone marrow microenvironment in vivo.  
 
4. Chondrogenic favorable microenvironment in vitro: 
For in vitro chondrogenic differentiation MSCs are needed to be kept in high density 3-D 
environment. This can be attained by aggregating the cells in mircomass pellets or as 
suspension in alginate. Different synthetic or biological scaffolds like agarose, collagen 
suspensions, fibrin gels and biopolymers can also be used, depending upon the aim of study 
(Bruckner et al., 1989; Kavalkovich et al., 2002; Hunziker, 2002). Alginate bead culture is an 
excellent tool for chondrogenic differentiation studies in vitro. Alginate is a linear 
polysaccharide which is soluble in aqueous solutions and cells can be homogenously 
suspended in it. It is cross-linked in presence of calcium or other divalent ions to form a 
polymerized hydrogel. Importantly, it can be easily resolubilized by a chelating agent (EDTA) 
to separate cells from the ECM (Hauselmann et al., 1994). 
Chondrogenic differentiation is a complicated process requiring well defined conditions, 
therefore, external fetal calf serum (FCS) normally used for proliferation of MSCs has to be 
substituted by defined medium supplement, like widely used ITS™. It contains insulin, 
transferrin, selenious acid and linoleic acid suspended in solution of bovine serum albumin. 
Insulin as a hormone supplement is necessary for survival of cells as it is involved in fatty 
acid and glycogen synthesis. Transferrin is an iron-binding protein for hormones and 
nutrients, therefore, it is vital for in vitro cell growth and selenious acid is a cofactor for 
glutathione peroxidase necessary for cell membrane integrity. Linoleic acid is an integral 
component of chondrogenic medium, like many unsaturated fatty acids it is an integral 
membrane component and important for cell growth. It is not a specific chondrogenic 
differentiation factor but in combination with Tgfß has profound stimulatory effect on 
chondrogenesis. Tgfß alone and in combination with dexamethasone exerts profound 
stimulatory effect on chondrogenesis (Johnstone et al., 1998; Lennon et al., 1995). The 
chondrogenic medium has to be enriched with proline because this amino acid is found in 
very high concentrations in extracellular matrices. Pro-x-gly-pro sequence motif appears very 
frequently in collagens where x is usually a neutral amino acid. Ascorbic acid is required as an 
electron donor, thus it contributes to collagen synthesis by acting as a co factor for lysine and 
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proline hydroxylation essential for the formation of typical-triple helical collagen structures 
(Chepda et al., 2001). 
As all the required conditions are met MSCs start to loose their fibroblast like characteristics 
and start expressing chondrocyte specific ECM which can be monitored by expression of 
chondrogenic markers. 
 
5. Chondrogenesis  
Chondrogenesis, one of the major differentiation pathways of MSCs, is the process which 
leads to formation of cartilage anlagen during endochondral ossification in skeletal 
development. It occurs autonomously in three separate mesenchymal lineages, cranial neural 
crest, sclerotome cells and lateral plate mesoderm cells. From cranial neural crest cartilage 
and bone of the head region arise, sclerotome gives rise to vertebrae and ribs while the lateral 
mesoderm generates limb cartilage (Goldring et al., 2006). It is important to note that in every 
case the same chondrogenic differentiation program is used independent of cell source or type 
of cartilage. Subsequently the same program is adapted for skeletal regeneration following 






Figure 4. Chondrogenic differentiation during endochondral bone formation. Schematic 
representation of different stages; growth and differentiation factors are listed on top of the 
arrows and transcription factors below the arrows. Stage specific ECM marker proteins are 
listed at the bottom of the figure.  Reproduced from Goldring 2006 (Goldring et al., 2006). 
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This osteochondral differentiation is a multistep process where every succeeding step is 
guided by the predecessor and its integrity is controlled by interplay between genetic and 
biomechanical forces. Every stage of the process is identifiable because of differentiation 
stage specific and tissue specific biochemical markers. Defined cell surface markers may be 
employed to identify a specific differentiation stage on the cellular level while mRNA can be 
utilized for gene expression analysis (Hall and Miyake, 2000). The first stage of chondrogenic 
differentiation is conversion of undifferentiated MSCs to committed osteochondroprogenitor 
cells and migration to the site of differentiation where they interact with epithelial cells. This 
leads to cell condensation (formation of high cell density regions) and growth arrest. 
Condensation on its own is a multistep process and involves intiation, establishment of 
boundary conditions, cells adhesion, proliferation, growth and eventual cessation of growth. 
Cells present at the centre of this condensation nodule first form pre-chondrocytes and then 
chondrocytes which start to produce cartilage matrix. In the growth plate chondrocytes 
undergo successive changes and after unidirectional proliferation become hypertrophic and 
attain the ability to calcify the matrix which is followed by cell death and replacement by 
osteoblasts (Fig.4) (Goldring et al., 2006; de Crombrugghe et al., 2000). Progression from 
condensation to overt chondrogenic differentiation requires down regulation of proliferation 
associated genes (e.g. N-CAM) and up regulation of differentiation associated genes as 
Col2a1, Col9a2, Col11a2, COMP and aggrecan. It is governed by many extracellular ligands 
and their receptors, nuclear receptors, transcription factors, DNA-binding proteins, matrix 
proteins, matrix modifiers as metalloproteinases and adhesion molecules (de Crombrugghe et 
al., 2000; Mundlos and Olsen, 1997; Lefebvre et al., 2001). Collagen X is the distinguishing 
marker of terminal differentiated chondrocytes, able to synthesize mineralized matrix 
followed by vascular invasion and cell death (Von der Mark et al., 1992). Ossification can be 
overtly detected by collagen I and osteocalcin gene expression (Fig.4).  
The family of homeobox containing (Hox) transcription factors play integral roles in 
epithelial-mesenchymal interaction. Major growth factors involved in condensation initiation 
are members of the transforming growth factor ß family (TGFß-1, 2 and 3) and fibronectin. 
Up regulation of differentiation after condensation is directly under influence of bone 
morphogenic proteins (BMP2-7) and fibroblast growth factors (FGF1, 2 and 9). Parathyroid 
hormone and parathyroid hormone-related peptide receptor (PTHrP) are induced by Indian 
hedgehog (Ihh) for transition of chondrocytes to hypertrophic chondrocytes.Transcription 
factor families with paired type DNA-binding homeodomain (Pax) and SRY-type high 
mobility group box DNA binding domain (Sox) have been shown to play important roles in 
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condensation and transition from condensation to overt differentiation (Hall and Miyake, 
2000; Shum and Nuckolls, 2002). For chondrogenic differentiation the most important 
transcription factor by far is Sox9 (Akiyama et al., 2002; Bi et al., 1999).   
 
6. Transcription factor Sox9 
Expression of all chondrogenesis associated genes including Col2a1, Col9a2, Col11a2, 
aggrecan, COMP and most of the Sox family genes, is suggested to be regulated by 
transcription factor Sox9 (Akiyama et al., 2002; de Crombrugghe et al., 2001). Hence, Sox9 is 
designated as master regulator of chondrocyte lineage formation. It has been reported to be 
expressed in all chondroprogenitor cells and also in differentiated chondrocytes. Its expression 
starts in chondroprogenitor cells, reaches a peak in resting and proliferating chondrocytes and 
is completely absent in hypertrophic chondrocytes. The pattern of Sox9 expression precedes 
Col2a1 gene expression in developing chondrocytes and it has been observed that MSCs can 
not condense without Sox9 (Chimal-Monroy et al., 2003). Heterozygous mutations in and 
around Sox9 cause skeletal dysmorphology syndrome and haploinsufficiency resulting in 
campomelic dysplasia, a lethal skeletal malformation syndrome and XY sex reversal 
(Mansour et al., 1995). Another role for Sox9 is suggested in gene regulation of cell-adhesion 
molecules. In skeletogenesis down regulation of Sox9 is required for transition of proliferating 
chondrocytes to hypertrophic chondrocytes which ultimately leads to endochondral 
ossification and chondrocytes death. Cbfa1, an integral transcriptional factor indespensible for 
osteoblastic differentiation also seems to be under direct or indirect control of Sox9 (Akiyama 
et al., 2002; de Crombrugghe et al., 2001). Several studies carried out in chondrocyte cell 
lines, mesenchymal stem cells, primary chondrocytes and on genes of chicken, mice, rats and 
human, have identified Sox9 as the key player of chondrocyte phenotype induction and 
maintenance. In short, Sox9 is not only the primary transcription factor involved in 
chondrocyte differentiation but it also has an earlier active role in chondrocyte progenitor cell 
determination, conserved across vertebrates (Chimal-Monroy et al., 2003; Bi et al., 1999; de 
Crombrugghe et al., 2001). Sox9 integrates several signalling pathways involved in regulation 
of cartilage differentiation associated gene expression and activity. For example, positive 
regulatory signals from FGFs (via MAPK) and BMP-2 (via cAMP), matrix degradatory 
signals from cytokines (JAK/STAT) or retinoic acids and PTHrP signalling in 
prehypertrophic chondrocytes are all involved in Sox9 mediated gene regulation. An 
important factor to consider is that the activity of Sox9 in these pathways may depend not 
only on the signalling molecules but also on the level of Sox9 gene expression itself, as it is 
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seen in human single allele mutation studies (Bi et al., 2001). Due to post natal fatality, 
attempts for generation of Sox9 null homozygous transgenic mice have been abandoned thus, 
Sox9 expression studies are limited to mouse embryo chimeras derived from Sox9-/- ES 
(Akiyama et al., 2002). Hence, use of new technologies and novel ideas for understanding 
Sox9 function and mode of action is vital. 
 
7. Animal models  
Many aspects of biology are similar in most or all organisms and 
often it is easier to study a particular aspect in one organism than 
in others. These much-studied organisms are commonly referred 
to as model organisms. Mammals share many basic biological 
functions, such as the regulation of cell division, the development of organ systems, and 
immune response. The rat is a principal model organism to link function to genes. The large 
number of inbred rat models and the vast amount of data available are helpful for studies of 
human physiology and pathology. These animals are a unique resource for studying and 
identifying genetic pathways relevant to some human diseases. Tissue engineering based 
approaches require pre clinical in vitro and in vivo studies. Though the mouse model is better 
characterized and is less cost and space intensive, a big advantage of the rat over the mouse 
model is bigger animal size which results in more cellular material. The rat system is also 
ideal for tissue engineering studies due to less inter-individual variation and easy availability 
of the cells. (http://www.ncbi.nlm.nih.gov/About/model/mammal.html).  
 
8. Future  
MSCs based therapeutic approaches for cartilage repair exhibit ample promise. The more 
effort goes in deciphering regulatory mechanisms of stem cells proliferation and 
differentiation the quicker we will reach the goal. Optimal application of MSCs for cartilage 
repair requires biodegradable scaffolds and proper signalling to maintain the articular 
phenotype of the newly formed cartilage. Factors and the involved pathways which influence 
geno- and phenotypical changes in MSCs during differentiation could be vital for ex vivo 
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Adult mesenchymal stem cells (MSCs) are adherent stromal cells of non-haematopoietic 
origin. Upon in vitro expansion they retain their self renewal capacity as well as their potential 
to differentiate into tissues of mesenchymal lineage including bone, cartilage, muscle, tendon 
and connective tissue. Amongst these cartilage is the only tissue which lacks self renewal 
capacity thus MSCs are an excellent tool for therapeutic regeneration of focal cartilage 
lesions. For optimal manipulation of MSCs identification and better understanding of 
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molecular mechanisms regulating differentiation pathways is needed. While many studies on 
genetic profiles of human MSCs exist; basal gene and protein profiles of adult rat MSCs has 
rarely being investigated. Rat is a widely used mammalian experimental model for preclinical 
studies. Therefore, this study undertook a comprehensive profiling of mRNA expression of 
osteo- / chondrogenesis related genes in undifferentiated and differentiated rat adult MSCs by 
using quantitative RT-PCR technology. A differential gene expression pattern was observed 
depending on osteo-chondral differentiation status of the cells. At protein level TIMP-1, 
MCP-1 and VEGF164α were detected in culture supernatant and CINC-2 and ß-NGF in the 
cell lysate of MSCs after an antibody array analysis. Our results provide a foundation for a 
more reproducible and reliable quality control of rat bone marrow derived MSCs used for 
osteo-chondro differentiation studies.   
   
 
Key words: rat marrow stromal cells, profiling, cytokines, gene expression, antibody array 
 
Introduction  
Cartilage cannot regenerate upon injury or degeneration, the exact reason of this incapacity is 
unclear, but lack of access to progenitor cells is often pointed out as a main reason. Adult 
osteo-chondroprogenitor bone marrow stromal or mesenchymal stem cells (MSCs) are known 
progenitors of tissue of mesenchymal lineage. These chondroprogenitor MSCs residing as part 
of bone marrow stroma in the medullary cavity of the bone are inaccessible to the avascular 
cartilage (Cancedda et al., 2003). They make up less then 1% of the bone marrow cellular 
population which is otherwise dominated by haematopoietic cells. In vitro expansion of bone 
marrow cells leads to separation of the stromal MSCs relying on their capacity of adherence to 
the plastic surface of the tissue culture vessels. Upon expansion these cells retain not only 
their self renewal capacity but also their differentiation competence (Friedenstein et al., 1976). 
This intrinsic competence can be invoked under controlled nutritional and mechanical 
conditions to differentiate MSCs into bone, cartilage, muscle, tendon and connective tissue 
(Bruder et al., 1994). MSCs have shown promise for ex-vivo cartilage regenerative medicine 
and for treatment of large bone defects (Quarto et al., 2001; Horwitz et al., 1999).  
Lack of common standards and of a precise definition of initial cell preparations is a major 
obstacle for MSCs based research and application. Genetic profiling of human MSCs for 
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trans-differentiation capacities has provided data on differential gene expression depending on 
origin and commitment status of MSCs from different tissue sources (Wagner et al., 2005). 
However, very little is known about the proteomic and genomic profile of MSCs which can 
qualify as osteo-chondroprogenitor cells. Knowledge of changes in expression pattern of 
matrix associated structural genes, of proteases and their inhibitors, transcription factors and 
adhesion molecules during osteogenesis and chondrogenesis are essential for providing proper 
conditions for in vitro differentiation of MSCs. 
It has been known that together with the other cells of bone marrow microenvironment MSCs 
contribute to an interactive network of cytokines, growth factors and matrix proteins to sustain 
existence and differentiation of haematopoietic stem cells (Dorshkind, 1990). However, what 
role the network plays in proliferation and differentiation of MSCs is still unknown. Some 
reports indicate differential gene expression of cytokines as IL-1, IL-6 and GM-CSF in MSCs. 
However, the studies are mainly restricted to gene expression analysis and do not address the 
protein.  (Majumdar et al., 1998; Kim et al., 2005). Knowledge of a basal cytokine protein 
profile in MSCs is essential to understand the effect of these cytokines on MSCs and their 
differentiation.  
Mammalian animal models like rat share many aspects of the human genomic, cellular and 
immunological structure. Large numbers of inbred models and subsequent vast amount of 
available data parallel to the small size and rapid development are advantages of employing 
rat MSCs for in-vitro studies.  However, genetic and proteomic expression profiling of rat 
MSCs is incomplete. Keeping in mind that the basic background profile of human MSCs 
cannot be taken at face value for rat MSCs, this study undertook a comprehensive profiling of 
baseline mRNA level of osteo-chondro related genes in undifferentiated adult rat MSCs which 
is subsequently compared with the changes in gene expression upon osteo-chondrogenic 
differentiation. Secondly, a basic protein profile of factors generated from undifferentiated 
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Material and Methods 
Isolation and cell culture of MSCs  
MSCs were isolated from rat bone marrow as described earlier (Ahmed et al., 2006). Briefly, 
bone marrow was removed from tibiae and femora of 6 week old male Sprague-Dawley rats 
by centrifugation (2000rpm for 3min). Homogenized bone marrow was cultured in 175cm² 
tissue culture flasks in proliferation medium containing 5% glutamate, 1% 
antibiotics/antimycotics and 10% FBS (Gibco, Invitrogen, UK) in α-MEM (Sigma Aldrich, 
Germany). Non-adherent cells were removed on the 3rd day and the adherent CFU-cells were 
proliferated until reaching 70% confluence. Magnetic associated cell sorting procedure 
(MACS- Miltenyi Biotech, Germany) was carried out according to the manufactures 
instructions; in short, expanded cells were incubated in suspension with 4µl of selected 
antibody / 106cells for 5min at 37°C followed by washing and incubation with goat anti-
mouse secondary antibody coupled with magnetic beads for 15min at 4°C. The suspension 
was passed through a magnetic column (Miltenyi Biotec´s LS-MACS columns); while 
labelled cells were retained by the magnetic field the flow through containing the unlabelled 
negative fraction was collected. After removing the column from the magnetic field the 
antibody labelled cells (positive fraction) was also flushed out. For both fractions cells were 
counted and stained. Antibodies used for MACS were directed against CD45 and CD49a 
(Chemicon, Germany), CD71 and CD106 (BD Bioscience, USA).  
 
Chondrogenic and osteogenic differentiation of MSCs  
For chondrogenesis, cells were cultured for 21 days in high density 3-D alginate cultures. To 
prepare the culture 107 cells/ml were suspended in 1.2% alginate. The cell- alginate amalgam 
was dropped into 102 mM CaCl2 solution via a syringe which resulted in formation of beads 
with a diameter of 2-3mm containing approx. 105 cells/bead. Beads were cultured in 2.3ml 
chondrogenic medium in 12 well tissue culture plates. 10 alginate beads were used for RNA 
isolation and gene expression analysis. Cells were released from alginate by incubation at 
37°C for 30min in 55mM sodium citrate and 0.15M sodium chloride buffer followed by cell 
recovery by 3min spin at 750xg. Chondrogenic medium contained: ITS+ premix (6.25µg/ml 
insulin, 6.25ng/ml selenium acid, 6.25µg/ml transferrin, 1.25mg/ml BSA and 5.35µg/ml 
linoleic acid (BD Biosciences, USA.), 110µg/ml pyruvate, 40µg/ml proline, 0.1µM 
dexamethasone, 50µg/ml ascorbic acid and 10ng/ml TGFß-3 (Johnstone et al., 1998) (R&D 
Systems) in α MEM high glucose (Gibco, Invitrogen, UK). Alginate sodium salts were 
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acquired from Sigma Aldrich, Germany (Cat# A0682-100G). Osteogenesis was induced for 
15 days in 6 well culture plates, 250,000 cells/ well were cultured as monolayer in osteogenic 
medium containing, 10% FCS, 1% pen/strep, 10nM dexamethasone, 50µg/ml Ascorbate 2-
PO4 and 10mM ß-Na glycerophosphate.  
 
Immunofluorescence 
For immunofluorescence analysis alginate beads were irreversibly polymerized by replacing 
CaCl2 with 100mM BaCl2 (Hauselmann et al., 1994). The beads were fixed with 4% 
paraformaldehyde and after sequential dehydration embedded in paraffin. 4µm sections were 
acquired and the deparaffinized and rehydrated sections were used for staining after 
hyaluronidase digestion. Undifferentiated MSCs were fixed with 4% paraformaldehyde.  
Slides were blocked for 1h at 37°C in 5% normal goat serum and 1% BSA in PBS containing 
Complete Mini 1:5 protease inhibitor solution (Roche, Germany). After washing with PBS 
cells were stained overnight at 4°C with monoclonal antibodies directed against collagen II, 
1:1000 diluted (Acris, Germany), CD49a, diluted 1:50 (Chemicon, Germany) and  D7fib, 
diluted 1:50 (Acris, Germany). The appropriate Alexa568 or Alexa488 conjugated secondary 
antibodies (goat anti mouse, 5 µg/ml; Molecular Probes, USA) were added for 1h at RT. After 
washing slides were permanently mounted with DAKO fluorescent mounting medium 
(DAKO, USA) and covered with cover slips. Slides were evaluated with scanning laser 
microscopy (C1 confocal microscope from Nikon, Germany) and photos were taken with a 
Nikon C4 camera and software. 
 
Histological analysis 
Osteogenically differentiated cells were washed with PBS and fixed with methanol for 10 
min. After rinsing with water staining was carried out for 2min with 1% alizarin red prepared 
in 25% ammonia. Stained cells were thoroughly washed and photographed with a Nikon C4 
camera after complete drying.  
 
RNA Isolation and reverse transcription 
RNA was isolated by an affinity column chromatography method with Ambion’s 
RNAqueous4-PCR kit according to the manufacturer’s protocol.  For removal of possible 
DNA contamination DNaseI enzyme (DNA-free, Ambion, USA) was used. RNA 
concentration was determined at 585nm wavelength with RiboGreen RNA quantification kit 
(Molecular Probes, USA). Conversion of 0.5-1µg of RNA to cDNA was done with 
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SuperScript II reverse transcriptase kit (Invitrogen, UK) in 20µl of total reaction volume in 
the presence of 40 units/µl recombinant ribonuclease inhibitor (RNase OUT®), 500µg/ml of 
Oligo-dT primers, 10mM dNTPs and 200 units of SuperScriptII enzyme in First-Strand 
Buffer and 0.1M DTT for 50min at 42°C followed by an extension period of 15min at 70°C.  
 
Relative quantitative PCR 
Relative quantitative PCR was performed using the SYBR Green Dye I on ABI 7000 Prism 
Sequence detection system (AB Systems, USA) according to manufacturer’s instructions. 
Briefly, 1µl of cDNA was amplified in 50µl final volume of 0.2µM of each primer suspended 
in SYBR green master mix (AB Systems, USA). Amplification parameters were identical for 
all primer pairs and were repeated for 40 cycles, denaturation occurred at 95°C for 0.15min 
and annealing at 60°C for 1min. ∆Ct values, i.e. difference in mRNA expression level of 
genes of interest to that of an endogenous control, ß-actin, was evaluated from three 
independent experiments and plotted on an inverse scale so that 0 indicates expression of the 
endogenous control and thus taken as the reference point for the genes of interest. Mean 
relative quantification (RQ) values were calculated by the software “RQ study application 
v1.1” (ABI Prism 7000 SDS software v1.1) according to the ∆∆Ct method using ß-Actin as 
endogenous control and undifferentiated MSCs (day 0) as calibrator. Primers were designed 
either with freeware Primer3 (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) or 
“Primer Express” software supplied by AB. All primers were manufactured at MWG – 
Biotech, Germany and are listed in table 1.  
 
Antibody array analysis 
RayBio™ (Tebu-bio, France) rat cytokine antibody array I for conditioned medium was used 
according to the manufacturer’s instructions. Briefly, first the membranes were blocked for 
30min in 5% BSA in 0.01M Tris buffer with 0.15M NaCl (pH 7.6) followed by overnight 
incubation at 4°C in 1ml of cell culture supernatant or cell lysates. After washing and 
incubation with biotin coupled anti-cytokine antibodies for 2h a second series of washing was 
performed and then the membranes were incubated with horse reddish peroxidase-conjugated 
streptavidin for 2h. Signals were detected with the provided detection solution using a CURIX 




Ahmed 2006  Profile of marrow stromal cells Chapter 2 
  
  
  25 
Statistical Analysis 
One way ANOVA and student t test were employed for quantitative PCR experiments 




Table 1: Primers used for quantitative PCR 
 
Gene   RefSeq#    Amplicon   Forward primer  Reverse primer 
     (bp)           (5´ - 3´)            (5´ - 3´) 
Alpha-10 XM_001063132   188 -tttcttcgggaaatcagagc      -tggatggagaagccaatctc 
Alpha-11 XM_001075650   170 -tggaggtccaacacttcctc      -gggtttcagtccctcctctc  
Aggrecan NM_022190       224 -ggccttccctctggatttag      -ccgcactactgtccaac 
BMP-7 AF100787       167 -gaaaacagcagcagtgacca    -gtggcgttcatgtaggagt  
ß-Actin NM_031144       104 -gtagccatccaggctgtgtt      -ccctcatagatgggcagagt 
Cbfa1  XM_34016         86 -gccgggaatgatgagaacta    -agatcgttcaacctggccact 
Col1a1 RGD61817*         59 -tccagggctccaacgaga      -ctgtaggtgaatccactgttgc 
Col2a1 NM_012929         60 -cccctgcagtacatgcgg      -ctcgacgtcatgctgtctcaag 
Col10a1 AJ131848*       247 -ccctattggaccaccaggta     -tctctgtccgctctttgtga 
Col16 a1 M92642         97 -gcctggtaccaaaggtgaaa     -catagcctggaggaccttga 
COMP NM_012834       167 -tgacttcgatgctgacaagg      -gaacgatctccattccctga 
Ihh  XM_343590       103 -atgaagacggccatcactcag   -cgcgccagtagtccgtacttat  
MMP-2 NM_031054       111 -gaccggtttatttggcgga        -ggcctcatacacagcgtcaat 
MMP-13 XM_343345         93 -acctgggatttccaaaagagg    -acacgtccttccctgagaaga 
Sox4  XM-344594         58 -ggcccatgaacgcctttat      -ctggatgaacgggatcttgtc 
Sox6  XM_215016         51 -gaaatccatgtccaaccaggac  -cgggcctgctcttcatagtaag  
Sox9  XM_343981       140    -ctgaagggctacgactggac     -tactggtctgccagcttcct 
Tbox2  XM_220810         71 -gcccactctccgtttgtatgag    -aggacgaggcatcggattc 
TIMP-1 NM_053819       136 -gattcgacgctgtgggaaat     -tttccgttccttaaacggcc 
TIMP-2 NM_021989       140 -ggcaagatgcacattaccctct   -atgtagcatgggatcatagggc 
Tgfß-3  NM_013174         86 -ttccttcttggccgtatttcc      -tgtgtgggatccagaatcca 
VEGFα NM_031836         71 -tggctttactgctgtacctcca     -tttctgctccccttctgtcgt 
VEGFR-2 NM_013062         95 -ttgcctagtcaagcagctcgt     -cgatggtctcaccaatggttg 
*Locus ID 
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Cellular morphology and surface antigen markers of MSCs 
Formation of CFU-F is one of the basic classification of bone marrow derived stem cells 
along with rapid adhesion and extended proliferation (Bianco et al., 2001). After in-vitro 
expansion of bone marrow isolated cells, colony forming units of fibroblast like cells (CFU-F) 
designated as MSCs readily adhered to the culture flasks and showed typical fibroblast like 
morphology (Fig 1a). Immunofluorescence analysis of the adherent cells exhibited positive 




Figure 1: Morphological 
characterization of MSCs 
CFU-F like marrow 
derived adherent cells (a) 
double stained with D7fib 
(red) and CD49a (green) by 
immunofluorescence (b) 
exhibit typical stem cells 
morphology. Dark red 
staining with alizarin red 
indicates calcified matrix 
formation after 15 days of 
osteogenesis in monolayer 
while the control culture 
remained unstained (c, d). 
Chondrogenically 
differentiated cells kept in 
alginate were stained with 
collagen II antibody. After 
21 days  (f) the positive 
signal was stronger when 
compared with the beads 




One of the major characterization criteria for MSCs is the retained differentiation potential 
upon expansion. MSCs were induced for 15 days in monolayer culture for osteogenesis and 
21 days for chondrogenesis in 3-D high density alginate cultures. Osteogenesis cultures 
stained positive for alizarin red indicating formation of calcified matrix while the un-induced 
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control cultures did not stain (Fig 1c-d). Chondrogenically induced cells exhibited clear 
collagen II staining of the surrounding matrix on day 21 of the culture as compared with day 0 
(Fig 1e-f). As a unique MSCs marker is not yet identified culture purity is usually determined 
by employing a consortium of positive and negative markers. In this study adherent cells were 
screened by magnetic cells sorting (MACS™) using three positive markers CD71, CD106 and 
CD49a. In addition, CD45, a haematopoietic marker used for negative selection revealed 
partial purity of MSCs with 75-85% of CD45-negative cells. 60-65% of the cells were CD71 




Figure 2: MACS sorting of bone marrow derived CD45+ cells  Separation by magnetic 
labelling of cells exhibiting CD71, CD49a and CD106 antigen and lack of CD45 antigen 
revealed 75-85% CD45- negative stromal cells with 60-75% of CD71, CD49a and CD106 
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Gene expression profiling  
With the help of quantitative RT-PCR and specific primers (Table 1) baseline mRNA 
expression of selected genes was determined. Subsequently, the MSCs were induced to 
differentiate into osteogenic and chondrogenic lineages and mRNA level was compared with 
the expression in un-induced undifferentiated cells.  
Among the most highly expressed genes in undifferentiated MSCs were integrin Alpha-11, 
VEGFa, Sox9, Sox4, Cbfa1,TGFß-3, TIMP-1, TIMP-2 and MMP-13; Col1a1 exhibited the 
highest expression of all analysed genes. Lowest expressed genes were VEGFr-2 (kdr), Ihh, 
Col2a1, and Col10a1. Expression of integrin Alpha-10, Sox6, Col16a1, Aggrecan, COMP and 






Figure 3a: Selected gene expression profile of adherent undifferentiated MSCs 
Quantitative mRNA expression level of selected groups of genes in undifferentiated MSCs 
(black bars) was normalized to ß-actin employing the ∆CT method using SYBR I Green dye. 
The calculated ∆CT value was subtracted from 40, the total number of PCR cycles. This value 
was plotted into a graph to show a positive correlation between bar length and gene 







Ahmed 2006  Profile of marrow stromal cells Chapter 2 
  
  
  29 
 
 
Figure 3b: Selected gene expression profile of adherent undifferentiated MSCs 
compared with differentiated cells Relative quantitative mRNA expression level of selected 
genes was determined by the ∆∆CT method using ß-actin gene expression as endogenous 
control. Expression level of each gene was compared after osteogenesis (stripped grey bars) 





Upon induction of osteogenic and chondrogenic differentiation gene expression of Alpha 11, 
TIMP-1 and TIMP-2 and Col10a1 remained mostly unaltered. After 21 days of chondrogenic 
favourable conditions mRNA level of integrin Alpha-10, Sox9, Sox6, Ihh, Col2a1, Col16a1, 
COMP, and MMP-2 were up regulated compared with uninduced MSCs. Culturing MSCs for 
15 days in osteogenic medium induced mRNA level of VEGF, VEGFr-2,Col1a1, and MMP-
13. Differentiation in general caused about 10 folds increase in mRNA level of Tbox2 and 
Cbfa1 independent of the differentiation pathway while Sox4 and Aggrecan expression was 
slightly higher at the end of chondrogenic differentiation. Chondrogenesis reduced the mRNA 
level of VEGFa and MMP-13 while osteogenesis had no significant negative effects on gene 
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Cytokine and growth factor profile of undifferentiated and differentiated MSCs  
Cell culture supernatants and cell lysates from undifferentiated and differentiated MSCs were 
analyzed for secretory molecules using an antibody array covering 15 cytokines plus ß-NGF, 
TIMP-1, CNTF, leptin and VEGFα-164. Only tissue inhibitor of matrix metalloproteases 
(TIMP-1) was secreted from undifferentiated as well as from differentiated MSCs, while 
monocyte chemoattractant protein (MCP-1) was exclusively secreted from undifferentiated 
MSCs. Secretion of vascular endothelial growth factor (VEGFα-164) was observed after 
induction of osteogenic and chondrogenic differentiation. When the same antibody array was 
examined with the cell lysate two additional molecules were identified. Nerve growth factor 
(ß-NGF) was detected in undifferentiated as well as in cells after osteogenic differentiation 
and cytokine induced neutrophil chemoattractant (CINC-2) was detected in low amounts after 
osteogenesis, both factors were undetectable after chondrogenic induction (Fig. 4).  
 
A. 
        MSCs Osteogenic   Chondrogenic 
 
  Cell lysate  
 
 
  Medium 
 
  
  Negative Control                                                                   




Figure 4: Comparison of cytokine profile of 
undifferentiated and differentiated MSCs 
Antibody array containing 19 different cytokines 
was used to compare protein profile of 
proliferated MSCs with MSCs after 15 days of 
osteogenic induction and after 21 days of 
chondrogenic induction (A.). Dot intensities 
higher than the negative control were accepted as 
positive expression. Among the 5 molecules with 
differential induction pattern TIMP-1 was present in all three conditions, MCP-1 was specific 
to undifferentiated MSCs. The induction profile of the remaining three factors was influenced 
by the differentiation state (B.). N=2 
* ** ς 
∆ 
*   TIMP-1 
 




+    CINC-2 
 
ς    ß-NGF 
+ 
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The remaining 14 proteins were undetectable in all culture conditions analysed, these include, 
CINC-3, Ciliary neurotrophic factor (CNTF),  fractalkine, GM-CSF, IFN-γ, IL-1α, IL-1ß, IL-
4, IL-6, IL-10, lipoplysacchride induced c-x-c chemokine (LIX), leptin, macrophage 
inflammatory protein (MIP-3α), and TNF-α. 
 
Discussion 
Cellular morphology and surface antigen markers of MSCs 
In the medullary cavity of bone marrow MSCs coexist with haematopoietic stem cells. In-
vitro the two cell populations can be easily separated because MSCs tend to adhere to the 
tissue culture plastic and form small colony like units arising from single cells (Pittenger et 
al., 1999). Formation of these colony forming units of fibroblast like cells (CFU-F) is one of 
the basic classification of bone marrow derived stem cells parallel to rapid adhesion and 
extended proliferation (Bianco et al., 2001). The CFU-F forming rat bone marrow derived 
MSCs used in this study showed CD 45-/low, CD106+. CD49a+ and CD 71+ antigen profiles, as 
determined by MACS after 7 days of expansion. CD106 (V-CAM) and CD71 (transferring) 
are well established positive markers for bone marrow derived osteo-chondro progenitor cells. 
CD49a alpha 1 integrin is expressed only on MSCS and not on other cells of bone marrow. 
CD45 is mainly expressed on haematopoietic cells and MSCs are known not to express this 
antigen.  
Immunofluorescence analysis further confirmed the identity of MSCs which stained positive 
for fibroblast marker D7fib and CD49a. The D7fib antigen is described as a specific marker 
for MSCs as suitable as STRO-1 and CD105 (Jones et al., 2002).  
BM-derived cells obtained by sole adherance to plastic surfaces are not a pure population with 
regard to their CD marker profile. MACS™ cell sorting shows that the cells are a 
heterogeneous population comprising of a small proportion of CD45-positive cells of 
haematopoietic origin and a large fraction of CD45-negative cells. It is described that both cell 
populations exert a mutual influence important for differentiation pathways. The role of 
MSCs in providing a supportive microenvironment for HSCs is well established and in some 
cases even direct interaction has been observed (Prockop, 1997). However, vice versa 
influence of haematopoietic cells in the differentiation of MSCs is still not answered 
satisfactorily, co transplantation of HSCs with MSCs in hematologic malignancy patients 
have indicated faster engraftment and low graft versus host disease (Lazarus et al., 2005). In 
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addition, we could demonstrate a positive effect of haematopoietic cells on the chondrogenic 
differentiation of MSCs in vitro (Ahmed et al., 2006). Therefore, investigation of gene and 
protein expression profile of MSC populations frequently isolated solely according to plastic 
adherance will be helpful for basic characterization.  
 
Gene expression profile  
Little information is available about baseline mRNA expression profile of rat multipotent 
MSCs. Here, we present profiling of osteo-chondrogenic related gene expression in 
undifferentiated and differentiated MSCs including growth factors, transcription factors, 
proteases and their inhibitors, structural components and adhesion molecules.  
Integrin subunit Alpha-11 was amongst the highly expressed genes, whereas only little Alpha-
10 mRNA was detected in undifferentiated MSCs. Integrin Alpha-11 is highly expressed in 
various mesenchymal tissues around the cartilage anlage in the developing skeleton. Its 
additional expression in MSCs of the intervertebral discs and in keratinocytes in the cornea is 
compatible with its role as receptor for interstitial collagens (Tiger et al., 2001). Integrin 
Alpha-10 is a chondrocyte specific major collagen II and IX -binding integrin integral to 
cartilage development and mature hyaline cartilage (Camper et al., 1998; Camper et al., 
2001).  In rat MSCs neither osteogenic nor chondrogenic differentiation alter Alpha-11 gene 
expression, contrary to Alpha-10 mRNA level which increased about 1000 folds during 
chondrogenesis. The ratio between Alpha-11 / Alpha-10 integrin gene expression makes these 
genes useful markers for monitoring the progression of MSCs differentiation towards 
particular lineages. 
Transcription factors which regulate osteo- and chondrogenic lineage as, Tbox2 (Brachyury), 
Sox9, Sox4 and Cbfa1 were also expressed in un-induced naïve MSCs. In early vertebrate 
embryonic development Tbox2 is involved in determination of mesodermal cell fates and 
patterning during limb bud formation, where it is restricted to subridge mesoderm (Liu et al., 
2003). Both, Sox9 and Tbox2 are essential components for the BMP-dependent onset of 
chondrogenesis (Hoffmann et al., 2002). Increase in Tbox2 gene expression after 
differentiation substantiates its role in osteo-chondrogenic cell fate determination. So far 
involvement of Tbox2 in the osteogenic pathway of MSCs has not been described and needs 
further investigations. Sox9 is expressed in all essential stages of chondrogenic development 
starting from pre-condensation nodules and including proliferating chondrocytes, however, 
the expression is abrogated in hypertrophic chondrocytes (Zhao et al., 1997). At that terminal 
differentiation stage inhibition is possibly regulated due to a negative feed back mechanism 
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accompanied by the activation of the PTHrP and Ihh signal cascade in pre-hypertrophic 
chondrocytes (Akiyama et al., 2002); (de Crombrugghe et al., 2000). After chondrogenic 
differentiation gene expression of both, Sox9 and Ihh was upregulated, indicating cells might 
be arrested in a pre-hypertrophic stage, corroborated by lack of gene expression of collagen X 
which is restricted to terminally differentiated hypertrophic chondrocytes (Schmid et al., 
1990).  Interestingly, master regulators of both the osteogenic pathway, Cbfa1, and 
chondrogenic lineage, Sox9, are both already expressed in un-induced MSCs. This implicates 
that the progenitor cells probably have entered a specific commitment stage which may have 
been triggered by cell culture conditions. Differential expression of both the master 
transcription factors might serve as marker for harvesting osteo-chondroprogenitor cells at 
different states of commitment thus allowing a separation of these populations.  
Factors of the Tgfß super family have been identified as important inducers and promoters of 
differentiation in human MSCs (Barry et al., 2001a). Therefore, high expression of Tgfß-3 in 
un-induced MSCs might be considered as a prerequisite for ECM structural components 
regulation during differentiation.  Structural components of the cartilaginous extracellular 
matrix like collagen II (Mendler et al., 1989), aggrecan and COMP (Hedbom et al., 1992; 
DiCesare et al., 1994) are known to be upregulated in MSCs during the chondrogenic 
differentiation pathway (Barry et al., 2001b). This makes them suitable as markers for 
discriminating between undifferentiated and chondrogenically differentiated MSCs. In 
undifferentiated rat MSCs collagen II and X displayed low basal gene expression indicating 
lack of chondrogenic differentiation, however, gene expression of aggrecan and COMP was 
observed. On the other hand collagen I showed undoubtedly the highest gene expression 
amongst all screened molecules which further increased during differentiation. Reduction of 
relative gene expression of collagen I during chondrogenic differentiation is desirable and 
underscores the development of a cartilaginous matrix. Little is known about expression 
profile of fibril-associated collagens with interrupted triple helices (FACIT) in MSCs, gene 
expression of collagen XVI in undifferentiated MSCs indicates a yet unknown role in 
proliferation or differentiation processes. Notably, collagen XVI mRNA level is upregulated 
during chondrogenesis compared with osteogenesis implicating a specific role in 
chondrogenesis. 
The results demonstrate high gene expression of VEGFα in un-induced MSCs with an 
increase during osteogenic differentiation. During osteoblasts differentiation angiogenic factor 
VEGF modulates matrix mineralization in an autocrine manner and up regulates the 
expression of its receptor (Mayer et al., 2005). VEGFα gene expression level appears as a 
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suitable marker for osteogenic committed MSCs while chondrogenic differentiation requires 
downregulation of VEGFα mRNA.  
The ability of MMPs to alter the activity or function of numerous proteins by proteolytic 
procession suggests that they are also involved in various cellular functions and matrix 
formation during development. Gene expression of MMPs and TIMPs in MSCs cultures has 
been reported earlier in studies on human MSCs of different origin (Silva, Jr. et al., 2003; 
Mannello et al., 2005). MMP-13 together with its inhibitors, TIMP-1 and -2 were highly 
expressed in un-induced MSCs indicating a role in stem cell migration as assigned to MMP-2 
(Cronwright et al., 2005). While TIMP-1 and -2 were not regulated during MCSs 
differentiation MMP-13 was controversely regulated during osteo-chondrogenensis. 
Downregulation of MMP-13 gene expression after chondrogenesis correlates with arrest of 
cells in a pre-hyperthrophic stage.  Relatively higher MMP-13 mRNA level after osteogenesis 
indicates progressing mineralization as MMP-13 along with alkaline phosphatase and 
osteocalcin is known to be involved in endochondral and intramembranous ossification 
(Tuckermann et al., 2000).  Notably, MMP-2 gene expression was elevated during  
chondrogenesis which may indicate beginning of late stage chondrogenesis as proteolytic 
activity of MMP-2 is vital for ECM turnover prior to hypertrophy (Aigner et al., 2001).   
 
Protein profiling of undifferentiated and differentiated MSCs  
Secretory cytokines, proteases and growth factors are key players in cell proliferation and 
differentiation. Mixed cultures of BM isolated MSCs are known to secrete haematopoiesis 
supportive cytokines. We speculated that the protein profile should differ according to the 
differentiation state of the MSCs. TIMP-1 was the only identified molecule to be secreted 
from undifferentiated as well as differentiated MSCs while monocyte chemoattractant protein 
(MCP-1) was exclusively secreted from undifferentiated MSCs. TIMP-1 is a multifunctional 
molecule apart from its biological activity as inhibitor of metalloproteinases,it is thought to be 
involved in regulation of cell growth and differentiation. Cell surface binding of TIMP-1 and -
4 has been reported, but the identification of specific cell surface receptors is missing (Stetler-
Stevenson and Seo, 2005). Therefore, TIMP-1 secreted by MSCs may act as inducer or 
repressor of specific factors necessary for commitment to specific differentiation pathways of 
MSCs. MCP-1, which recruits monocytes into ischemic tissue and stimulates chemotaxis, is 
secreted exclusively from un-induced MSCs. MSCs are described to secrete this chemokine 
which is speculated to be involved in homing of circulating stem and progenitor cells to the 
region of injuries and thus contribute to healing (Kinnaird et al., 2004; Liu and Hwang, 2005) 
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Notably, osteoarthritic chondrocytes secrete MCP-1 and it is suggested that it contributes in 
triggering inflammatory mechanisms involved in persistence of joint diseases (Pulsatelli et al., 
1999). MCP-1 secretion could be used as a marker for un-induced MCSs which becomes 
attenuated during chondrogenic and osteogenic differentiation processes.  
Secretion of VEGFα-164 was induced only after the cells were subjected to osteogenic and 
chondrogenic differentiation. VEGF influences vascular permeability and is a strong 
angiogenic protein indispensable for neovascularisation during embryonic skeletal 
development (Goldring et al., 2006). VEGF as a multifaceted protein may have a role in 
induction of metalloproteinases during late stage of chondrogenesis marking the onset of 
hypertrophy (Pufe et al., 2004). Lack of VEGF secretion in undifferentiated MSCs might be 
taken as an indicator for a relatively pure MSC population moistly devoid of hematopoietic 
and endothelial progenitor cell contamination. Latter stem cells are known to express and 
secrete VEGF (Rehman et al., 2003; Iba et al., 2002) The discrepancy in low gene and high 
protein secretion profile of VEGFα after chondrogenic differentiation is very likely due to 
post translational regulation. VEGF production is known to be regulated at translational level 
as overexpression of transcription factor c-Myc related with rapid induction of tumors, also 
leads to 10 fold higher VEGF production while the gene expression level remains unaltered. 
The mechanism of action is most probably higher ribosome biogenesis which increases 
translation efficiency of selected mRNA (Mezquita et al., 2005). 
When the same antibody array was examined with the cellular lysates, two additional 
molecules were identified, ß-NGF was detected in undifferentiated as well as in cells after 
osteogenic differentiation and cytokine induced neutrophil chemoattractant (CINC-2) was 
detected only after osteogenesis. CINC-2 attracts neutrophils and has been suggested to 
inhibit acute inflammation indicating its role is osteogenesis could be anti-inflammatory 
(Nakagawa et al., 1994). So far this chemkine has not been determined in MSCs but in bone 
marrow derived macrophages exposed to pro-inflammamtory cytokins (Crippen et al., 1998) 
It is known that early non-committed MSCs with high cologenic potential bind to antibodies 
against NGF receptor (Quirici et al., 2002) and that undifferentiated bone marrow derived 
cells express NGF together with other neurotrophic factors (Yaghoobi and Mowla, 2006). 
This is in line with the production of ß-NGF in undifferentiated MSCs. The naïve MSCs loose 
ß-NGF upon chondrogenic differentiation but keep it under osteogenic conditions which 
suggests a role of ß-NGF in osteogenesis as a trophic factor stimulating collagen synthesis and 
expression of specific osteogenic marker as alkaline phosphatase (Yada et al., 1994). In 
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mandibular distraction osteogenesis elevated expression of NGF has been demonstrated (Park 
et al., 2006).  
In conclusion, we were able to demonstrate gene expression and secretion of molecules from a 
mostly CD45-negative bone marrow derived cell population which may be crucial for MSCs 
fate determination and sustenance. Identification and better understanding of the molecular 
events characterizing differentiation of MSCs which allows discrimination among specific 
differentiation stages is a prerequisite for manipulation of MSCs to regenerate complex tissues 
as cartilage and bone.  
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Adult mesenchymal stem cells (MSCs) can be readily isolated from bone marrow, expanded 
in culture and subsequently subjected to differentiation into various connective tissue 
lineages. In general, for animal studies separation of MSCs from other bone marrow derived 
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cells is achieved by sole adherence to plastic surface of tissue culture flasks, however, this 
procedure produces a heterogeneous cell population containing CD45-positive haematopoietic 
cells (HCs) and haematopoietic stem cells (HSCs) as well. It is well known, that such mixed 
cell cultures consisting of cocultures of differentiated somatic cells with adult stem cells 
promote differentiation towards specific cell lineages. For determining the effect of the CD45-
positive cell population on the differentiation potential of MSCs we have sorted out the bone 
marrow derived adherent cells by immunomagnetic technique (MACSTM) to attain a 
subpopulation of CD45-depleted cells. Here, we show that the presence of adherent CD45-
positive HCs not only promote expression of the chondrogenic marker genes Col2a1, COMP 
and Sox9, but also of Col1a1, Col10a1 and to a certain degree Cbfa1 in MSCs when cultured 
in an appropriate three-dimensional environment. These observations constitute a step 
towards unravelling the influence of haematopoietic cells on chondrogenic differentiation of 
MSCs.  
 




Adult bone marrow stromal cells regarded as mesenchymal stem cells are progenitors of 
connective tissue cells, thus are excellent candidates for chondrogenic differentiation studies. 
The progeny of adult stem cells includes both daughter stem cells and committed progenitors 
with a more restricted differentiation potential. These progenitors in turn give rise to 
differentiated cell types. Mesenchymal stem cells (MSCs) can differentiate under specific 
cultural and physical conditions into multiple mesenchymal lineages namely, osteocytes, 
chondrocytes, adipocytes, astrocytes and myocytes (Pittenger et al., 1999b; Cancedda et al., 
2003). Bone marrow consists of primarily non-adherent haematopoietic cells and 
haematopoietic stem cells (99%) along with a minor population of MSCs (≤1 %). Both of the 
stem cell types are known to co-exist and have been suggested to cooperate in one another’s 
differentiation (Bianco et al., 2001). The role of MSCs in haematopoietic microenvironment 
formation is beginning to unravel and it is assumed that the presence of adherent MSCs and 
their progeny facilitates HSCs differentiation into granulocytes and erythrocytes both in vivo 
and in vitro (Galmiche et al., 1993; Prockop, 1997a; Majumdar et al., 1998b). Conversely, in 
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depth studies concerning the role of HSCs in MSCs commitment and differentiation towards a 
distinct lineage are scarce.  
Adult rat MSCs are routinely isolated from tibio-femoral bone marrow by relying solely on 
their adherence to the plastic surface of tissue culture flasks (Friedenstein et al., 1976; Caplan 
and Bruder, 2001). The isolated cells constitute a heterogeneous population which always 
contains HCs therefore; obtaining a pure population of non-haematopoietic cells remains 
difficult. This haematopoietic cell fraction varies depending on the species; being relatively 
high in initial cultures of mouse marrow cells (Phinney et al., 1999) and less than 30% in 
human cell cultures. In rat marrow stromal cells this trend has not been studied thoroughly, 
although the presence of haematopoietic cells in primary (7 days) and secondary (18 days) 
bone marrow cultures has been indicated (Herbertson and Aubin, 1997). Human and murine 
MSC studies show subsequent loss of haematopoietic cell surface markers when cultures are 
maintained for 2 or 3 weeks. Prior to differentiation experiments the haematopoietic cell 
population is often separated from MSCs by employing a magnetic associated cell sorting 
(MACS) system. The system immunologically separates different cell types by labelling cell 
surface antigens with magnetic beads followed by sorting through a magnetic column. As a 
unique identifying marker for MSCs is still lacking a negative selection protocol is carried out 
using CD34 (My10) or CD45 (leukocyte common antigen) for exclusion of undesired 
positively labelled haematopoietic cells.  
One of the major differentiation pathways of MSCs occurs along the chondrogenic lineage 
which can happen autonomously in three separate mesenchymal cell lines, cranial neural 
crest, sclerotome cells and lateral plate mesoderm cells (von der, 1999). The first stage of 
chondrogenic differentiation is conversion of undifferentiated MSCs to committed 
osteochondroprogenitor cells leading to cell condensation and growth arrest. The major 
proteins involved in condensation initiation are either fibronectin or belong to the 
transforming growth factor ß family of proteins (TGFß-1, -2 and -3). Cells present at the 
centre of the condensation nodules first form pre-chondrocytes and then chondrocytes which 
start to produce cartilage matrix marked by up regulation of structural protein genes as 
Col2a1, Col9a2, Col11a2, aggrecan and COMP. Expression of chondrocyte marker genes is 
controlled by members of the Sox-family, in particular Sox9 has been characterized as a 
master transcription factor with essential direct or indirect regulatory effects exerted along the 
entire chondrogenic differentiation pathway. It is expressed in all chondroprogenitor cells and 
also in differentiated chondrocytes (Bi et al., 1999; de Crombrugghe et al., 2000b; Mundlos 
and Olsen, 1997; Lefebvre et al., 2001) .  
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In this study we have evaluated the degree of haematopoietic cell coexistence in primary 
cultures of rat MSCs and their influence on the chondrogenic differentiation potential of 
MSCs. We have determined the difference in chondrogenic marker gene expression of 
heterogeneous MSCs isolated by sole adherence to plastic surfaces compared to that of a more 
homogeneous subpopulation of MACS sorted CD45-depleted cells.  
 
Material and Methods 
MSC isolation and primary cell culture  
A modified version of the MSCs isolation procedure from rat bone marrow was optimized 
(Dobson et al., 1999; Maniatopoulos et al., 1988). Briefly, 6 week old male Sprague - Dawley 
rats were killed with CO2 and tibiae and femora were aseptically removed. The bones were 
cut from the middle and centrifuged in a 1.5ml tube at 2000 rpm for 3min (mini centrifuge-
Eppendorf). The centrifuged bone marrow cells were collected and homogenized with 18g, 
21g and 23g needles and seeded at the rate of 2.5 x 105 cells/cm2 in 175cm² tissue culture 
flasks in proliferation medium containing 5% glutamate, 1% antibiotics/antimycotics (Gibco.) 
and 10%FBS (Gibco, Invitrogen, UK; Lot No.: 40F7430K) in α-MEM (Sigma Aldrich, 
Germany). All non-adherent cells were removed on the 3rd day and the adherent cells were 
proliferated.  
 
Magnetic separation of cells (MACS) 
When the flasks were ~75% confluent (9-11 days) cells were harvested with trypsin digestion. 
Separation procedure was carried out according to the manufactures instructions; in short, 
cells were incubated with 4µl of CD45 antibody/106cells for 5min at 37°C followed by 
washing and a second incubation with goat anti-mouse secondary antibody coupled with 
magnetic beads (Miltenyi Biotech) for 15min at 4°C. The suspension was passed through a 
magnetic column (Miltenyi Biotec´s LS-MACS columns); while labelled cells got coupled to 




20,000 cells/chamber were seeded on chamber slides (Biocoat slides, BD, Bioscience) and 
incubated overnight at 37°C and 5% CO2. Cells were blocked for 1h at 37°C in Complete 
Mini 1:5 (Roche, Germany) plus 5% normal goat serum and 1% BSA in PBS. After washing 
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with PBS cells were stained with monoclonal antibodies directed against CD45 (Cb1 1502, 
Chemicon), CD68 and D7Fib (Acris, Germany) in 1:50 dilution ratio overnight at 4°C. The 
appropriate Alexa568 or Alexa488 conjugated secondary antibodies (goat anti mouse, 5 
µg/ml; Molecular Probes, US) were added for 1h at RT. After washing slides were 
permanently mounted with DAKO fluorescent mounting medium (DAKO, USA) and covered 
with coverslips. Slides were evaluated with scanning laser microscopy (C1 confocal 
microscope from Nikon) and photos were taken with a Nikon C4 camera and software. 
 
Flow cytometric analysis 
Cells obtained from 1 animal (approx. 8x 107 cells, as determined after NH4Cl lysis of the 
erythrocytes) were seeded in 4x 150cm2 flasks (5x 105 cells/cm2). The cells were left to 
adhere 1, 2, 3 or 4 days before non adherent cells were removed. Cells were trypsinized on 
day 7 after the isolation and resuspended in PBS. The cell suspension was first blocked for 15 
min at 4°C with sheep serum followed by incubation with antibodies against rat CD45-PE 
(mouse IgG1 against rat CD45, Acris Antibodies, Germany), CD29-FITC (Hamster IgM 
against rat CD29, BD Pharmingen, USA) and with corresponding isotype controls for 30min 
at 4°C. Cells were washed with PBS containing sodium azide and bovine serum albumin and 
resuspended. Shortly before the FACS – analysis propidium iodide was added to each sample 
in order to discriminate the dead cells which were excluded from the evaluation. All 
measurements were performed on a FACSCalibur® instrument (Becton Dickenson, USA) 
with CellQuest data acquisition software (Becton Dickenson, USA). Data analysis was 
preformed with WinMDI 2.8 software (free access on http://facs.scripps.edu/software.html). 
A minimum of 1x104 viable cells was acquired per data set.  
 
Chondrogenic differentiation 
A batch of adherent cells (undepleted) was subjected directly to chondrogenesis favourable 
condition, the other batch was depleted of CD45-positive cells by MACS prior to 
chondrogenic differentiation experiments. For chondrogenic differentiation, high density 3-D 
cultures were attained by preparing cell-alginate amalgam in 1.2% alginate at a concentration 
of 107 cells/ml. 2-3mm cell-alginate beads containing approx.105 cells/bead, were formed by 
dropping the suspension into 102 mM CaCl2 solution. The culture was carried out in 12 well 
tissue culture plates for 4 weeks; medium was changed every 2-3 days. 10 alginate beads were 
removed every 7th day for RNA isolation and gene expression analysis. To release the cells 
from alginate the beads were incubated for 30min at 37°C on a shaker in 55mM sodium 
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citrate and 0.15M sodium chloride buffer; cells were recovered after 3min spin at 750xg. The 
chondrogenic medium contained; ITS+ premix (6.25µg/ml insulin, 6.25ng/ml selenium acid, 
6.25µg/ml transferrin, 1.25mg/ml BSA and 5.35µg/ml linoleic acid. BD Biosciences, USA.), 
110µg/ml pyruvate, 40µg/ml proline, 0.1µM dexamethasone, 50µg/ml ascorbic acid and 
10ng/ml TGFß-3 (Johnstone et al., 1998) (R&D Systems) in α MEM high glucose (Gibco). 
Alginate sodium salts were acquired from Sigma Aldrich, Germany (Cat# A0682-100G). 
 
RNA Isolation and reverse transcription 
RNA was isolated by an affinity column chromatography method with Ambion’s 
RNAqueous4-PCR kit according to the manufacturer’s protocol.  For removal of possible 
DNA contamination, isolated RNA was incubated for 1 h at 37°C in 2 Units of DNaseI 
enzyme (DNA-free, Ambion). RNA integrity was determined on 0.8% Agarose-formaldehyde 
gels. The RiboGreen RNA quantification kit (Molecular Probes) was used for determination 
of RNA concentration at 585nm wavelength. For RNA conversion to cDNA, Invitrogen´s 
SuperScript II reverse transcriptase kit was used with 0.5-1µg of RNA in 20µl of total 
reaction volume in presence of 40units/µl recombinant ribonuclease inhibitor (RNase OUT®). 
Reverse transcription was carried out with 500µg/ml of Oligo-dT primers, 10mM dNTPs and 
200 units of SuperScriptII enzyme in First-Strand Buffer and 0.1M DTT for 50min at 42°C 
followed by an extension period of 15min at 70°C.  
 
Relative quantitative PCR 
Relative quantitative PCR was carried out with SYBR Green Dye I on ABI 7000 Prism 
Sequence detection system (Applied Biosystems) according to manufacturer’s instructions. 
Briefly, 1µl of cDNA was amplified in 50µl final volume of 0.2µM of each primer suspended 
in SYBR green master mix (AB Systems).Amplification parameters were same for all primer 
pairs and were repeated for 40 cycles, denaturation at 95°C for 0.15min and annealing at 60°C 
for 1min. Mean relative quantification (RQ) value evaluated from three independent 
experiments was plotted on a semi logarithmic graph. RQ values were calculated by the 
software “RQ study application v1.1” (ABI Prism 7000 SDS software v1.1) according to the 
∆∆Ct method using ß-Actin as endogenous control and undifferentiated MSCs (day 0) as 
calibrator. Primers were designed with either Primer3 (http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi) or “Primer Express” software supplied by AB. All primers 
were manufactured at MWG – Biotech and are listed in table 1. Prior to RQ studies, a CT 
value (cycle threshold) standard curve, with 10 folds diluted cDNA, was plotted to determine 
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PCR efficiency of each primer pair only 90-100% efficient primers were used. The efficiency 
was determined with 10(1/-S) –1, where S is the slope of the curve (Ginzinger, 2002).  
 
Statistical Analysis 
One way ANOVA and student t test were employed for quantitative PCR experiments 
performed in triplicate. Results obtained by flow cytometry are the average of 4 independent 
experiments ± standard error of mean. The level of significance was determined by Turkey´s 




Table 1: Primers used for quantitative PCR 
 
Gene / RefSeq# Amplicon (bp)  Primer (5´ - 3´) 
ß-Actin  104  forward -GTAGCCATCCAGGCTGTGTT-3´ 
NM_031144    reverse -CTGTAGGTGAATCGACTGTTGC-3´ 
 
Col1a1  59  forward -TCCAGGGCTCCAACGAGA-3´ 
RGD61817*    reverse -CTGTAGGTGAATCGACTGTTGC-3´ 
 
Col2a1  60  forward -CCCCTGCAGTACATGCGG-3´ 
NM_012929    reverse -CTCGACGTCATGCTGTCTCAAG-3´ 
 
Col10a1  247  forward -CCC TAT TGG ACC ACC AGG TA -3´ 
AJ131848*    reverse -TCT CTG TCC GCT CTT TGT GA -3´ 
 
COMP  167  forward -TGACTTCGATGCTGACAAGG-3´ 
NM_012834    reverse -GAACGATCTCCATTCCCTGA-3´ 
 
Sox9   140     forward -CTGAAGGGCTACGACTGGAC-3´ 
XM_343981       reverse -TACTGGTCTGCCAGCTTCCT-3´ 
 
Cbfa1   86  forward -GGCCGGGAATGATGAGAACTA-3´ 
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D7Fib ICD 68 G CD 45 H 
CD 68 D F D7Fib E CD 45 
B CD 45 A CD 68 D7Fib C
CD 68 J CD 45 K D7Fib L
Results  
MSC isolation procedure and CD expression profile  
To determine the influence of adherence time of rat bone marrow cells on the presence of 
CD45-positive haematopoietic cells we left the cells to adhere for 3, 4 and 5 days before non-
adherent and weakly attached cells were removed. Upon immunofluorescence analysis the 
adherent cells showed a D7fib+, CD68+ and CD45+/low expression profile regardless of the 
time of removal of non-adherent cells. Figure 1 shows the representative immunomicrographs 
of the cells left to adhere for 3 days and compares the staining of non-sorted and MACS- 
sorted cells after the first passage. Non-sorted cells, left for 3 days to adhere before medium 
removal, are contaminated with CD45-positive cells (Fig.1A-C). After magnetic sorting, most 
of the CD45-positive cells were excluded, leaving a CD45-depleted cell fraction (Fig.1D-F). 
However, we still observe few rounded cells among the CD68 positively stained fraction 
(Fig.1D) of unknown surface antigen characterization. The CD45-positive cell fraction 





Figure 1: Morphological 
characterization of MSCs 
Immunofluorescence 
imaging of heterogeneous 
adherent MSCs (A, B, C) and 
CD45-depleted MACS sorted 
cells (D, E, F), showing 
typical fibroblast like spindle 
shaped cells, while CD45-
positive cells (G, H, I) are 
small and rounded in 
appearance. The negative 
controls for all three 
antibodies used are unstained 
(J, K, L). All 3 cell types are 
CD68- and D7fib- positive 
while the CD45-depleted cell 
population does not exhibit 
CD45 harbouring cells (E). 
 Magnification is 20x for all 
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Quantification of CD45-positive cell contamination of primary MSC cultures 
In order to quantitate the ratio between haematopoietic CD45-positive cells and MSCs we 
employed three colour flow cytometry (FACS) which allowed for a distinction between the 




Figure 2: FACS analysis of bone 
marrow derived stem cells prepared 
by adherence to plastic Representative 
dot-plot (out of 3 experiments) of rat 
MSCs isolated by adherence to plastic 
after 7 days of cell culture. The lower 
right quadrant contains CD29 –highly 
positive and CD45-depleted MSCs while 
the upper right quadrant contains HCs 
with a CD45 – positive and CD29-low 
expression profile (A). 
Proportion of CD45-positive (black bars) 
and CD45-depleted (open bars) cells 
from rat MSCs isolated by adherence to 
plastic in relation to the time of the first 
medium change and therefore, removal 
of non-adherent cells (B). 
Total yield of CD45-depleted (open 
bars) and CD45-positive (black bars) 
bone marrow derived cells after 7 days 
of cell culture (*p< 0,05; **p< 0,01). 
Yield of cells is normalized to cell 
number achieved when the non-adherent 
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Figure 2B shows that the fraction of CD45-positive haematopoietic cells was not influenced 
by the adherence time after cell isolation. We mostly found about 20-30 % of the attached 
cells in bone marrow cell cultures to be CD45-positive when selected according to sole 
adherence to plastic surfaces. Flow cytometric results were concurrent with the observations 
made after immunofluorescent staining. In one out of four experiments we detected variations 
between 10 - 40% in individual flasks. We observed that CD45-depleted cells expressed 
CD29 stronger than CD45-positive cells (Fig.2A) which offers an additional selection 
parameter. In cultures where non-adherent cells were removed on days 3 and 4, we obtained a 
significantly increased number of desired CD45-depleted MSCs compared to removal on day 
1 and 2 (Fig.2C). Apparently, 3 to 4 days were a more appropriate duration for the adherent 
fraction to get acclimated to the cell culture conditions, hence exhibit a firmer attachment to 
the cell culture plastics.  
 
Effect of CD45-positive cells on gene expression levels of Col1a1, Col2a1, Col10a1, 
COMP, Sox9 and Cbfa1 
During the time course of cell culture we observed a strong increase in relative mRNA levels 
of COMP and collagen II, while Sox9 mRNA levels exhibited a moderate up regulation 
(Fig.3A, B, D). Collagen X gene expression remained undetectable the first three weeks of 
cell culture, however, at day 28 expression of this collagen was found to be induced (Fig.3C). 
The internal control gene, ß-Actin, remained unaltered during the complete time course of cell 
culturing (Fig. 3G). Comparing gene expression of CD45-depleted cells and the non-sorted 
population, we found collagen I gene expression to be increased in the non-sorted cell 
population during the culture period, while it became decreased in CD45-depleted MSCs. 
However, in CD45-depleted cells collagen I was still expressed at a relative higher level as in 
freshly isolated hip articular chondrocytes (Fig.3E). Notably, the non-sorted cells displayed a 
strikingly higher up regulation of collagen II, COMP and Sox9 gene expression compared to 
the CD45-depleted MSCs throughout the culture period. In the non-sorted population collagen 
II gene expression is up regulated at average about 25 fold, COMP gene expression about 10 
fold, collagen X expression about 23 fold and Sox9 mRNA levels about 3 fold if compared to 
CD45-depleted MSCs. For collagen I gene expression we have observed a significant 
difference only between the two groups at day 14 and 28, where the adherent MSCs 
demonstrated an up regulation resulting in a 3-5 fold higher gene expression if compared to 
CD45-depleted MSCs.  
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Figure 3: Chondrogenic gene expression profile of adherent MSCs, CD45-depleted 
MSCs and remixed control cells. Relative quantitative mRNA expression level of 
chondrogenesis specific genes as COMP (A) Col2a1(B) and Col10a1 (C), Sox9 (D), 
Col1a1(E), and Cbfa1 (F) was determined by employing the ∆∆CT method using SYBR I 
Green dye. Expression level of housekeeping gene, ß-actin was determined as a controlling 
indicator of cell viability (G) and is expressed as positive logarithm of CT-values. Expression 
level of each gene was compared between adherent (black bars), CD45-depleted (open bars) 
and remixed control cells (crossed bars). Grey shaded bars indicate relative gene expression 
level of freshly isolated hip articular chondrocytes. Number of experiments = 3 
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Collagen I remained up regulated from day 14 on in adherent cells while CD45-depleted 
MSCs exhibit an increasingly down regulation during the time course of cell culture. We also 
observed a striking difference in the collagen X expression pattern between non-sorted and 
CD45-depleted cells. The collagen X mRNA expression profile of CD45-depleted cells 
experienced only a moderate increase of about 3.3 fold at the end of the culture period while 
adherent cells up regulated their mRNA level about 76 fold compared to day 0 (Fig. 3C). 
Notably, Cbfa1 gene expression is differentially regulated with respect to the two cell 
populations (Fig.3F). On day 1 Cbfa1 mRNA level is significantly higher in adherent cells 
(4.7 fold) and also in chondrocytes (ca. 2.0 fold) compared to CD45-depleted cells. This 
pattern became inverted at day 28 with CD45-depleted cells exhibiting an elevated expression 
(1.7 fold) compared to the adherent MSCs. In between these time points, relative gene 
expression of Cbfa1 is similarly regulated in both cell populations.  
In remixed control cell populations (30% CD45-positive cells with 70% CD45-depleted cells) 
collagen II, X, I, Sox9 and Cbfa1 gene expression profile resembles closely that of adherent 
cells (Fig.3B, C, D, E, F) and exhibits no significant differences. Only COMP gene expression 
at day 14 of the culture period significantly differs from adherent cells but the level at day 21 
and 28 shows no difference to non-sorted cells (Fig. 3A). ß-actin gene expression profile is 
similar for all three culture conditions (Fig.3G).  
 
Discussion 
Adult bone marrow is the major source of haematopoietic stem cells and mesenchymal stem 
cells (Pittenger et al., 1999a). In animal studies, adherence to tissue culture plastic is accepted 
as a satisfactory parameter for attaining marrow stromal cell population depleted of 
haematopoietic cells. However, when employing FACS analysis for surface antigen 
characterization we observed a contamination of these non-sorted MSCs with 20-30% of 
CD45-positive cells. For additional characterization of sorted and non-sorted cell population 
we applied immunofluorescence staining for CD68 and D7Fib. The D7Fib antigen constitutes 
a fibroblast specific molecule of yet unknown function, supposedly a specific marker for 
MSCs as suitable as STRO-1 and CD105 (Jones et al., 2002). We observed expression of the 
D7Fib antigen on adherent CD45-positive cells; however, these cells displayed a rounded 
morphology compared to the fibroblast-like CD45-depleted cells. CD68 and its murine 
analogue macrosialin, a member of the lamp family, appear to have a rather limited tissue 
distribution, being found on macrophages, Langerhans cells and dendritic cells (Ramprasad et 
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al., 1996). Notably, we have found all adherent cells CD68-positive suggesting that in non-
committed, undifferentiated cells, this protein might exhibit a different distribution pattern 
and possibly exert functions related to cell–cell or cell–ligand interactions (Fukuda, 1991).  
CD45-positive haematopoietic cells were always detected in MSC cultures, regardless of the 
time of the first change of culture medium. This indicated a persistent presence and 
attachment of CD45-positive cells in the MSC environment when no further selection based 
on specific surface antigens is carried out. Adherence to the tissue culture plastic alone is a 
weak discriminating criterion for a homogeneous MSC population, because neural cells, 
monocytes and macrophages are also known to be isolated according to their adherence to 
plastic surfaces (Delles et al., 2002; Kiefer et al., 1991; Majumdar et al., 1998a). The presence 
of CD45-positive haematopoietic cells and the variation of their proportion in primary 
cultures of MSCs could explain the occurrence of extensive variations usually seen in 
differentiation experiments with bone marrow derived cells. 
The fact, that CD45-depleted cells expressed CD29 stronger than CD45-positive cells offered 
us an easier separation of two populations and limited the possible existence of more than two 
major subpopulations in our cultures. The integrin ß1 subunit CD29 exhibits a broad tissue 
distribution, including lymphocytes, endothelia, smooth muscle, and epithelia (Springer, 
1990) and plays an important role in cellular processes, e.g. embryogenesis and HSC 
development. Although we did not find the haematopoietic cell fraction to vary according to 
the time of removal of non-adherent cells we observed a correlation between adhesion time 
and yield of CD45-depleted marrow stromal cells. In parallel, cell adhesion plus proliferation 
could also be promoted by the prolonged presence of the non-adherent fraction via cytokine 
release and / or cell-cell contacts. A comparable effect of haematopoietic cells on MSC 
proliferation has been observed for megakaryocytes and platelets (Castro-Malaspina et al., 
1981). According to our results we decided to leave the cells to adhere for 3 days before 
performing differentiation experiments. 
Differentiation studies of haematopoietic stem cells have demonstrated, that the small number 
of adherent MSCs present in total bone marrow aspirates provide an important 
microenvironment for growth of HSCs and their differentiation into several blood borne cell 
types. In long-term cultures of HSCs, these adherent cells even interact directly with the 
haematopoietic precursors (Prockop, 1997b). Here, we could show that vice versa adherent 
CD45-positive haematopoietic precursor cells create a microenvironment which may enhance 
expression of particular marker genes in MSCs. For studying the effects of contaminating 
CD45-positive cells we prepared a relatively homogeneous population of CD45-depleted 
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MSCs by immunogenic depletion of CD45-positive cells. Both, the heterogenic adherent cells 
and the CD45-depleted subpopulation were subjected to chondrogenic favourable 3-D 
environment by formation of a cell alginate amalgam. For control purposes in order to assure 
that difference in gene expression profile between sorted and unsorted MSCs is due to 
depletion of CD45-positive cells and not because of general depletion of differentiation 
competent cells or due to cell damage caused by the sorting process, we prepared a third 
population of remixed cells (30% CD45-positive mixed with 70% CD45-depleted cells) 
following MACS preparation which was treated according to the differentiation protocol used 
for adherent and sorted cells.  
We monitored relative gene expression of collagen II (Mendler et al., 1989) and COMP 
(Hedbom et al., 1992; DiCesare et al., 1994) as examples for structural extracellular matrix 
proteins highly specific for hyaline cartilage. Additionally, we have investigated Sox9 as a 
master transcription factor imperative for chondrogenic differentiation (de Crombrugghe et 
al., 2000a) and collagen I as differentiation control for a gene normally not active in healthy 
hyaline cartilage (Rossert et al., 2000) but occurring together with collagen II in fibrocartilage 
(Nerlich et al., 1998).  Gene expression of collagen X, specific for terminal differentiated 
hypertrophic chondrocytes in the calcifying zone of cartilage and secondary ossification 
centres within the growth plate (Schmid et al., 1990) indicates maturation of  MSCs towards 
an undesired cartilage condition. 
Gene expression of Cbfa1, a transcriptional activator for osteoblastic differentiation during the 
process of endochondral ossification is analyzed for monitoring differentiation towards 
osteogenic condition. Cbfa1 is also expressed in pre-condensation stage during early 
development in a cell type with the potential to become either a chondrocyte or an osteoblast. 
In later developmental stages expression of this transcription factor is restricted to 
prehypertrophic and hypertrophic chondrocytes where it acts as a hypertrophic differentiation 
inducer (Karsenty, 2001; Takeda et al., 2001). 
The observed gene expression profile indicates not only a beneficial influence of CD45-
positive cells on the differentiation process of MSCs towards the chondrogenic lineage. It also 
shows that when culture time is extended beyond 28 days chondrogenically differentiating 
MSCs might enter the prehypertrophic / hypertrophic differentiation cascade and proceed 
towards terminal differentiation. Interestingly, usage of chondrogenic culture medium does 
not prevent up regulation of Cbfa1 and collagen X. This indicates either a not yet defined 
influence of medium components (i.e. TGF-ß or dexamethasone) on intrinsic cell derived 
factors (i. e. signalling molecules, proteases, transcription factors) which are involved in 
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regulation of the chondrogenic differentiation cascade or a medium independent process 
occurring by default through paracrine interaction of MSCs. A variety of growth factors i.e. 
members of the TGF-ß superfamily, IGF-1 and bFGF could account for gene modulating 
effects in our system. (Bohme et al., 1995) (Recklies et al., 1998) (Murakami et al., 2000) 
(Horton, Jr. et al., 1989).   
In conclusion, we demonstrated that bone marrow derived fibroblast like CD45-depleted rat 
MSCs share a heterogeneous cellular environment with ~20-30% CD45-positive HCs, if no 
other selection procedure than adherence to plastic is employed. Our differentiation results 
indicate that adherent CD45-positive haematopoietic cells may create a microenvironment 
promoting differentiation of MSCs towards the chondrogenic lineage by up regulating 
specific genes. However, expression of undesired genes as collagen I and collagen X is 
likewise promoted by HCs. On the contrary, at early condensation stage HCs strongly 
increase gene expression of Cbfa1 thus supporting chondrogenic differentiation of MSCs, 
while at a later differentiation stage when Cbfa1 plays an integral role in hypertrophy the 
regulation appears to be independent of the presence of HCs. 
We speculate that the stromal CD45-positive population in toto is responsible for regulation 
of gene expression. The heterotrophic nature of bone marrow derived cells suggest that in vivo 
interactions of different cell types is very likely and should be addressed accordingly. 
Characterization of additional subpopulations of CD45-positive cells according to their 
surface antigens and determination of their potential influence on gene expression may 
elaborate this point further more. Studies using conditioned media are needed to clarify 
whether physical contact between cells or paracrine factors, alone or in concurrence, are 
necessary for promoting gene expression leading to chondrogenic differentiation and 
maturation of MSCs. Identification and isolation of factors which are capable of modulating 
genes involved in differentiation and dedifferentiation processes of chondrocytes is vital for in 
vitro engineering of cartilage tissue repair. 
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Limited regeneration capacity of cartilage is mainly due to lack of access to progenitor cells. 
The only known chondroprogenitor cells for adult cartilage tissues are multipotent marrow 
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stromal or mesenchymal stem cells (MSCs). In vitro lineage differentiation studies on these 
precursor cells usually require a cue from externally added growth factors of the TGFß 
superfamily. We hypothesise that signalling factors secreted by cartilage tissue may substitute 
for external growth factors. To study such paracrine communication between allogenic rat 
articular cartilage and MSCs embedded in alginate beads a novel coculture system without 
external growth factors has been established. Successful chondrogenic differentiation in 
MSCs was induced and the impact of cartilage on differentiating MSCs was observed at two 
culture stages. Firstly, elevated expression of Sox9 at the initial stage indicated early 
induction of chondrogenic differentiation. Secondly, late stage repression of collagen X 
indicated arrest of differentiation prior to hypertrophy. Four soluble signalling molecules were 
identified in the culture supernatant: vascular endothelial growth factor alpha (VEGF-164α), 
matrix metalloprotease (MMP) -13 and tissue inhibitors of MMPs (TIMP-1 and TIMP-2). 
These factors could be traced back either directly to the cartilage tissue or to the MSCs 
influenced by the presence of cartilage. The identified factors may have a mutual impact on 
the control and regulation of differentiation of both the chondrocytes and MSCs.  
 
Key words: rat mesenchymal stem cells, chondrogenic differentiation, coculture, signalling 
factors, cartilage, MMP-13, collagen X 
 
Introduction 
A defect in articular cartilage caused by aging, chondral injury or a degenerative disease is 
seldom repaired, causes persistent pain and restricts mobility. Generally, the avascular nature 
of cartilage is held responsible for the lack of spontaneous rejuvenation; more specifically it is 
probably due to the deficiency of chondroprogenitor cells (Magne et al., 2005). As 
chondrocytes are the only cell type of cartilage tissues and bone marrow derived MSCs are the 
only known chondroprogenitor cells, it is in interest of cartilage regenerative medicine to 
understand and identify molecular events characterising their growth and differentiation 
(Lefebvre and Smits, 2005). 
Under specific culture conditions and proper stimulation MSCs can differentiate into multiple 
mesenchymal lineages including osteocytes and chondrocytes. The first stage of chondrogenic 
differentiation is conversion of undifferentiated MSCs to committed osteo-chondroprogenitor 
cells leading to cell condensation and growth arrest. The major proteins involved in 
condensation initiation are fibronectin and proteins of the transforming growth factor ß 
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superfamily (TGFß1-3 and BMP1-7) (Barry et al., 2001). Cells present at the centre of the 
condensation nodules first form pre-chondrocytes and then chondroblasts / chondrocytes 
which start to produce cartilaginous extracellular matrix (ECM) marked by upregulation of 
structural protein genes as col2a1, col9a2, col11a2 and aggrecan. Collagens make up to 60% 
of the hyaline cartilage protein bulk; among them the most dominant (90-95%) form of 
cartilaginous collagen is collagen type II which forms a fibrillar alloy structure together with 
type XI and IX collagens and non-collagenous proteins (Mendler et al., 1989). Gene 
expression of collagen type X which according to the concept of endochondral ossification 
indicates the final step of chondrocyte maturation serves as a marker for hypertrophic and 
terminally differentiated chondrocytes (Reddi, 1994).   
The molecular basis of regulatory mechanisms involved in chondrogenic lineage signalling 
cascade are not sufficiently understood, however, they are known to involve numerous growth 
factors, proteases and cytokines in a strictly controlled time dependent manner. Major players 
imperative for proper skeletogenesis belong to proteases of MMP-family and growth factors 
of VEGF family. For example, activity of MMPs and their endogenous inhibitors (TIMPs) is 
not only fundamental to skeletal growth and repair, but also to their pathology. One member 
of this large family of matrix degrading MMPs, MMP-13 is predominantly expressed both, in 
osteoarthritic cartilage and in hypertrophic and calcifying cartilage of the mammalian growth 
plate (Wu et al., 2002; Johansson et al., 1997). Together with other collagenases, and their 
endogenous inhibitors like TIMP-1, MMP-13 plays a significant role in collagen turnover by 
cleaving collagen II, additionally, it also degrades collagen X (Knauper et al., 1996; Mitchell 
et al., 1996). VEGF, expressed by hypertrophic chondrocytes, is considered as an essential 
coordinator of chondrocyte death, chondroclast function, ECM remodelling, angiogenesis and 
bone formation in the growth plate thereby hold responsible for proper endochondral 
ossification (Gerber et al., 1999). Little is known how these soluble factors affect 
differentiation pathways decisions and integration processes of chondroprogenitor MSCs. 
Chondrogenesis is controlled by several transcription factors, important players are members 
of the Sox- and Cbfa- family. In particular, Sox9 has been characterized as a master 
transcription factor with essential direct or indirect regulatory effects along the entire 
chondrogenic differentiation pathway. It is expressed in all chondroprogenitor cells and in 
differentiated chondrocytes but not in hypertrophic cells (Bi et al., 1999; de Crombrugghe et 
al., 2000; Mundlos and Olsen, 1997; Lefebvre et al., 2001). Direct control of hypertrophy 
involves Cbfa1, also known as RUNX2, the major osteogenic transcription factor. Expression 
of Cbfa1 increases during maturation of chondrocytes and is necessary for inducing gene 
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expression of collagen X (Inada et al., 1999; Goldring et al., 2006) and MMP-13 in terminally 
differentiated chondrocytes (Porte et al., 1999). For a normal skeletal development and 
maintenance a co-ordinated regulation of these chondrogenic differentiation associated genes 
is critical. 
This in vitro study aimed to identify soluble signalling factors mediating a paracrine cross talk 
of differentiated cartilage tissue with undifferentiated MSCs. We have designed and set up a 
co-culture system of rat MSCs and allogenic articular cartilage chips under serum-free 
chondrogenesis favourable 3D- conditions. Our results indicate that externally added growth 
factors are dispensable for the induction of the chondrogenic differentiation pathway in rat 
MSCs embedded in alginate beads. Coculture of MSCs with differentiated cartilage induces 
up regulation of Sox9 gene expression in MSCs and causes suppression of collagen X 
biosynthesis and secretion presumably mediated by cartilage secreted factors. Using 
zymographic techniques and an antibody array we have detected VEGF-164α, TIMP-1, -2 and 
MMP-13 in the coculture supernatant. These molecules originate in part from cartilage 
explants and could be important players in regulation and control of chondrogenic 
differentiation. 
 
Materials and methods 
Cell isolation, coculture and differentiation   
MSCs from rat bone marrow were isolated as described earlier (Ahmed et al., 2006c). Briefly, 
bone marrow removed by centrifugation from tibiae and femora of 6 weeks old male rats was 
seeded at a concentration of 2.5x 105 cells/cm2 and proliferated in α MEM medium containing 
5% glutamate, 1% pen/strep and 10% FBS (Invitrogen, UK). Cells from ~75% confluent 
flasks were harvested and high density 3-D cultures were attained by preparing a cell-alginate 
amalgam in 1.2% alginate (Sigma, USA) at a concentration of 107 cells/ml. Alginate beads of 
105 cells/bead were formed by dropping the suspension into 102mM CaCl2 solution and 10 
beads per insert (1µm pore size, BD Bioscience, USA) were placed in 12-well tissue culture 
plates. One hip cartilage explant cut in 3 pieces was placed in the bottom well. The culture 
was carried out for 3 weeks in serum-free chondrogenic medium with medium change every 
2-3 days. The chondrogenic medium contained ITS+ premix (6.25µg/ml insulin, 6.25ng/ml 
selenium acid, 6.25µg/ml transferrin, 1.25mg/ml BSA and 5.35µg/ml linoleic acid; BD 
Biosciences, USA), 110µg/ml pyruvate, 40µg/ml proline, 0.1µM dexamethasone, 50µg/ml 
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ascorbic acid (Johnstone et al., 1998) in α MEM high glucose (Invitrogen, UK). Additionally, 
10ng/ml TGFß-3 (R&D Systems, USA) was added to the culture medium of control 
monocultures. Samples of cells, tissue and culture supernatant were taken once a week for 
gene and protein expression analysis. Alginate beads were depolymerised by 30min 
incubation in 55mM sodium citrate and 0.15M sodium chloride buffer at 37°C on a shaker; 
cells were recovered after 3min centrifugation at 750xg. Osteogenesis was induced for 19 
days in 6 well culture plates, 250,000 cells/well were cultured in osteogenic medium 
containing, 10% FCS, 1% pen/strep, 10nM dexamethasone, 50µg/ml ascorbate 2-PO4 and 
10mM ß-Na glycerophosphate. At the end of the culture time cells were fixed with methanol 
for 10min and stained for 2min with 1% Alizarin Red. 
 
RNA isolation, reverse transcription and quantitative PCR analyses 
All molecular biology techniques were carried out as described earlier (Ahmed et al., 2006b). 
Briefly, RNA was isolated by an affinity column chromatography method with Ambion’s 
RNAqueous4-PCR kit according to the manufacturer’s protocol. Contaminating DNA was 
removed with DNaseI enzyme (DNA-free, Ambion, USA). Invitrogen´s SuperScript II 
reverse transcriptase kit was used for conversion of 0.5-1µg of RNA into cDNA with 
500µg/ml of oligo-dT primers and 200 units of SuperScriptII enzyme. Relative quantitative 
PCR was carried out in triplicate with SYBR Green Dye I master mix using an ABI 7000 
Prism Sequence detection system (Applied Biosystems, USA). Amplification parameters were 
as follows, denaturation at 95°C for 15sec, annealing at 60°C for 1min in 40 cycles repeats. 
Relative quantification (RQ) values were calculated by using ABI Prism 7000 SDS software 
v1.1 employing the ∆∆Ct method with ß-actin as endogenous control and undifferentiated 
MSCs freshly suspended in alginate (day 0) as calibrator. Mean RQ values were plotted on a 
semi-logarithmic graph. Primers (table 1) were designed with either Primer3 or “Primer 
Express” software (Applied Biosystems, USA). All primers were manufactured at MWG – 
Biotech, Germany.  
 
Immunofluorescence 
Alginate beads were incubated for 30min in 100mM BaCl2 for irreversible polymerization 
(Mok et al., 1994). Then the beads were fixed with 3% paraformaldehyde (PFA), sequentially 
dehydrated with alcohol and then embedded in paraffin. 4-8µm sections were cut with a 
microtome (Leica, Germany) and 2 sections per slide were mounted. Slides were fixed again 
in 3% PFA and submerged in xylol for 5min to remove paraffin. Sections were sequentially 
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rehydrated and incubated for 1h in blocking buffer containing PBS with 1% BSA. 1:50 
dilution of collagen II polyclonal antibody (R1039, Chemicon, USA) was used for overnight 
incubation followed by incubation with Alexa488 conjugated secondary antibodies (goat anti 
rabbit, 5µg/ml; Molecular Probes, US). Slides were permanently mounted with DAKO 
fluorescent mounting medium (DAKO, USA) and evaluated with scanning laser microscopy 
using a C1 confocal microscope (Nikon, Germany). Photos were taken with a Nikon C4 




Table 1  Primers used for quantitative PCR 
Gene / RefSeq# Amplicon (bp)  Primer (5´ - 3´) 
ß-Actin  104  forward -GTAGCCATCCAGGCTGTGTT-3´ 
NM_031144    reverse -CCCTCATAGATGGGCACAGT-3´ 
 
Cbfa1   86  forward -GGCCGGGAATGATGAGAACTA-3´ 
XM_34016    reverse -AGATCGTTGAACCTGGCCACT-3´ 
 
Col1a1  59  forward -TCCAGGGCTCCAACGAGA-3´ 
RGD61817*    reverse -CTGTAGGTGAATCGACTGTTGC-3´ 
 
Col2a1  60  forward -CCCCTGCAGTACATGCGG-3´ 
NM_012929    reverse -CTCGACGTCATGCTGTCTCAAG-3´ 
 
Col10a1  247  forward -CCC TAT TGG ACC ACC AGG TA -3´ 
AJ131848*    reverse -TCT CTG TCC GCT CTT TGT GA -3´ 
 
Sox9   140     forward -CTGAAGGGCTACGACTGGAC-3´ 




Collagen isolation  
Secreted collagens were isolated from the culture supernatant  after pepsin digestion 
(Bruckner et al., 1989b). 1ml of medium was incubated for 2h on a rotary mixer with 
10mg/ml pepsin followed by overnight salt precipitation in 4.5M NaCl. After centrifugation at 
14,000xg for 30min at 4°C the protein pellet was precipitated overnight with absolute ethanol 
at -20°C. After a second centrifugation step the protein pellet was dissolved in 60µl of loading 
dye containing 0.8M urea. Samples were separated under denaturing conditions on a 4.5%-
15% gradient SDS-PAGE gel followed by Coomassie Brilliant Blue R250 staining (Serva, 
Germany).  
 
Ahmed 2006 Effect of cartilage on chondrogenesis Chapter 4 
 
  69 
Pulse-Chase   
After 21 days in chondrogenic favourable environment alginate suspended cells cultured in 
the presence of TGFß-3 were metabolically labelled for 1h in labelling DMEM-HG medium 
without methionine and cystein (#21013-024, Invitrogen, UK), as described previously 
(Grassel et al., 1996). Briefly, cell culture inserts containing the alginate beads were removed 
from cocultures and pre-incubated in the labelling medium without radioactive isotopes for 
1h. Afterwards beads were labelled in absence of cartilage with freshly added 2ml labelling 
medium plus 3.7MBq of [35S]- methionine and cystein (Tran 35S- label from Qbiogene/ICN-
USA) for 1h at 37°C (pulse). Labelling medium was then removed and after 2 washing steps 
with PBS the labelled cells were placed back in the culture vessel; in case of coculture 
together with cartilage. Newly secreted collagens were chased by continuing the culture in 
chondrogenic medium for 4h at 37°C. 1ml cell culture supernatant was retrieved after 0.5h, 
1h, 2h and 4h of chase time. Secreted collagens were extracted, as explained above and 
samples (each ~155 cpm) were separated on a 4.5-15% gradient SDS-PAGE under reducing 
conditions followed by Coomassie Brilliant Blue R250 staining. The destained and fixed gels 
were incubated for 30min in Amplify™ solution (Amersham Biosciences, UK), dried and 
developed for max. 21 days at -80°C. The radiographic images (Hyperfilm™ MP- Amersham 
Biosciences, UK) were acquired with CURIX 60 film developer (Agfa, Germany).  
 
Immunoblotting  
Western blotting was carried out with MSCs, cartilage explants and alginate cell fraction 
lysates. 0.5 mg cartilage explants were pulverized in a freezer mill and the finely powder 
extract was treated similar as the cells. Briefly, ~106 cells were lysed by suspending the cell 
pellet in 80µl of  250mM Tris buffer (pH 6.8) containing 6% EDTA, 4% SDS, 40mM DTT, 
20% glycerine, 0.002% bromophenol blue and 1:10 protease inhibitors (Complete Mini, 
Roche, Germany). Cells were heated for 5min at 60°C immediately followed by incubation 
for 10min at 100°C. Cell debris was precipitated by centrifugation at 14000xg for 30min at 
4°C and protein containing supernatant was TCA-precipitated and subjected to 4.5-15% SDS-
polyacrylamide gel electrophoresis. Prestained protein standards within a range of 7.5 to 
207kDa (BioRad, Germany) were used as molecular weight markers. Proteins were 
electrotransfered to a nitrocellulose membrane for 3h at 4°C. To reduce unspecific binding the 
membrane was blocked for 1h in blocking buffer (5% dry milk in PBS containing 0.1% 
Tween 20). Blots were incubated overnight with polyclonal antibodies against collagen I, 
(R1038 Acris, Germany), MMP-2 (AB 809, Chemicon, Germany, 1:100) and MMP-13 
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(RP1MMP13, Triple Point Biologics, USA, 1:1000). Detection was performed using 
Horseradish-peroxidase coupled secondary anti-rabbit antibodies (A2074, Sigma, USA; 
1:50000). Signals were visualized with ECL reagent (Pierce, USA) and the membrane was 
exposed to blue light sensitive autoradiography film (Pierce, USA). For dot blot analysis, 1ml 
of cell culture supernatant was extracted with 20% TCA solution for 30min at 4°C. Extracted 
protein was pelleted by centrifugation at 14000xg for 5min and washed twice with chilled 
acetone. After the final washing step the pellet was resuspended in 40µl PBS. 1µl of the 
resuspended protein was spotted and air dried on a nitrocellulose membrane. After blocking 
for 1h the membrane was incubated overnight with an antibody against TGFß-1/2/3 (sc-7892, 
Santa Cruz, USA, 1:200) and developed as above.  
 
Antibody array analysis 
RayBio™ rat cytokine antibody array I for conditioned medium (Tebu-bio, France) was used 
according to the manufacturer’s instructions. Briefly, the membranes were blocked for 30min 
in 5% BSA in 0.01M Tris buffer with 0.15M NaCl (pH 7.6) followed by overnight incubation 
at 4°C in 1ml of cell culture supernatant. After washing and incubation with biotin coupled 
anti-cytokine antibodies for 2h membranes were again washed and afterwards incubated with 
HRP-conjugated streptavidin for 2h. Signals were detected with the solution provided with the 




For gelatine and reverse gelatine zymography, aliquots of culture medium were mixed with 
equal volumes of two fold concentrated sample loading buffer (2mM EDTA, 2% SDS, 20% 
glycerol, 0.02% bromophenol blue, 20mM Tris/HCl, pH 8.0) and subjected to electrophoresis 
on 1% gelatine containing SDS-polyacrylamide gels. For gelatine zymography 4.5 - 15% 
gradient gels were used. Reverse zymography was carried out on 15% SDS-polyacrylamide 
gels in which 25% conditioned macrophage medium was included as MMP-source. Both 
types of gels were washed twice for 30min in 2.5% Triton-X 100, rinsed in distilled water, 
and developed for 16h at 37˚C in 50mM Tris/HCl pH 8.5 containing 5mM CaCl2. Finally, the 
gels were stained with Coomassie Brilliant Blue R250 (Serva, Germany) to visualize protease 
activity and were photographed.  
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a. b.
c. d.
Incubation of 14C-labelled collagen X with culture supernatant from MSCs  
(14C)-proline labelled collagen X was produced and isolated from IGF-I stimulated cranial 
chicken sternum chondrocytes as described elsewhere (Bohme et al., 1995b).  Equal amounts 
(1000 cpm) were incubated with aliquots of differently conditioned cell culture media or PBS 
for 7h at 37°C and analysed by 4.5-15 % gradient SDS-PAGE gel electrophoresis under 
reducing conditions followed by fluorgraphy as described  (Bruckner et al., 1989a).  
 
Statistical Analysis  
One way ANOVA and student t test were employed for quantitative PCR experiments which 
were performed in triplicate.  
 
Results 
The coculture model 
Differentiation potential of the isolated MSCs was determined by cell culture under 
osteogenic and chondrogenic favourable conditions. Positive Alizarin Red staining indicating 
osteogenesis and collagen II staining indicating chondrogenesis confirmed differentiation 
potential of the multipotent MSCs (Fig. 1). Cellular composition of the MSCs was screened 
previously by immunofluorescence and magnetic sorting for selected surface markers. These 




Figure 1. Multidifferentiation potential of bone marrow 
extracted MSCs. After 19 days culture in osteogenic 
differentiation medium accumulation of calcified ECM is 
evident by positive staining with Alizarin Red (a) compared 
with the MSCs cultured in proliferation medium (b). 
Chondrogenic differentiation potential of MSCs was 
established by positive collagen II staining after 21 days in 
chondrogenic favourable 3-dimensional environment (c) 
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Figure 2. The coculture model Schematic representation of the coculture model carried out 
in serum-free chondrogenic medium (A). Dot blot analysis of TGFß secretion into the culture 
supernatant by monocultured cartilage and monocultured MSCs during the period of culture 
(B). mRNA expression levels of ß-actin in the cartilage explants and in alginate suspended 
MSCs were determined by RT-PCR as an indicator of cell viability. Lane 1-3: coculture 
MSCs from day 7, 14 and 21.  Lane 4-6: cartilage explants from day 7, 14 and 21 (C). 
Western blot analysis of cartilage explant shows lack of collagen I secretion; in comparison 





A coculture system of cartilage tissue explants and multipotent MSCs suspended in 1.2% 
alginate was set up in tissue culture inserts placed into 12 well culture plates under serum-free 
conditions. The inserts separated MSCs from cartilage chips by a 1µm porous membrane, thus 
restricting the contact between the explant and MSCs to soluble diffusible molecules (Fig. 
2A). Cartilage explants secrete growth factor TGFß until day 14, from day 21 on TGFß 
secretion is strongly reduced and becomes undetectable in culture supernatant. MSCs totally 
lack TGFß secretion (Fig. 2B). The viability of both, the cartilage explants and MSCs was 
determined at mRNA level with RT-PCR. The unchanged band intensities for the 
housekeeping gene ß-actin indicate sustained vitality of MSCs and cartilage tissue throughout 
the culture period (Fig. 2C). Cartilage tissue samples were screened for contaminating bone 
tissue by western blot analysis of collagen I in culture supernatant. Lack of collagen I 
secretion in cartilage explants indicate absence of bone tissue (Fig. 2D).  
 
Effect of cartilage on gene expression profile of Sox9 and Cbfa1 
To account for the regulatory effect of Sox9 and Cbfa1 in chondrogenic differentiation of 
MSCs, expression of these transcription factors was investigated by qRT-PCR. Application of 
chondrogenic culture conditions resulted in an early increase in gene expression level of 
transcription factor Sox9 on the first day of culture (day 1). Cartilage exerted an impact on 
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Sox9 gene expression within 7 days as the cocultured MSCs showed significant increase in 
Sox9 mRNA expression when compared with the monocultures. The increment was 





































Figure 3. Relative changes in gene expression of transcription factor Sox9 and Cbfa1 
Relative gene expression level of Sox 9 (A) and Cbfa1 (B) assessed during culture time by 
qRT-PCR employing the ∆∆CT method using SYBR I Green dye. Target gene expression 
was normalized to gene expression in MSCs on day 0, which was used as a calibrator and 
constitutes the baseline at 1. Expression level of each gene from coculture (dotted bars) and 
monoculture (white bars) was compared with MSCs cultured in chondrogenic medium with 
addition of 10ng / ml TGFß-3 (chondrogenesis control) (black bars). Grey bar indicates 





However, from day 14 onwards Sox9 gene expression was reduced below the level of 
undifferentiated MSCs (Fig. 3A). Cbfa-1 gene expression was induced about 3-5 fold at day 1 
in alginate cultures of MSCs, remained stable until day 14 and became reduced to starting 
values after 21 days. The presence of cartilage did not influence relative induction of gene 
expression level of Cbfa-1 (Fig. 3B). Induction of Sox9 and Cbfa1 gene expression did not 
require external TGFß-3 as the mRNA levels during the initial (Sox9) and the middle (Cbfa1) 
stages of the culture were equivalent to the control culture.  
 
Effect of cartilage on gene expression profile of Col1a1, Col2a1 and Col10a1 and their 
biosynthesis  
To identify the effect of cartilage explants on chondrogenesis of MSCs, expression and 
biosynthesis of different collagens were monitored. Altogether Col1a1 gene expression 
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remained suppressed throughout the 3 weeks of culture became gradually reduced during the 
timeline of culture independent of cartilage (Fig. 4A).  
 
 
Figure 4. Relative gene expression of Col1a1 and Col2a1 and subsequent protein 
secretion Relative quantitative mRNA expression level of a marker for fibroblast-like cells, 
Col1a1 (A) was compared with a marker for chondrogenesis, Col2a1 (B) by qRT-PCR 
employing the ∆∆CT method using SYBR I Green dye. As calibrator gene expression of day 
0 MSCs constitutes the baseline at 1. Expression level of each gene was compared between 
coculture (dotted bars) and monoculture (white bars). MSCs cultured in chondrogenic 
medium with addition of 10 ng / ml TGFß-3 were regarded as chondrogenesis control (black 
bars). Grey bar indicates relative gene expression level of freshly isolated hip articular 
chondrocytes serving as positive control. N=3.  
 
Analysis of collagen chain secretion (C). Collagens were precipitated from culture medium, 
pepsin digested, separated on a 4.5%-15% gradient SDS-PAGE under reduced conditions and 
stained with Coomassie Blue. N=3.  
 
 
Assessment of collagen secretion from 
mono- and cocultured MSCs by 
employing the pulse-chase method (D). 
After 21 days in presence of TGFß-3 
cocultured cells were separated from 
cartilage explants and like monocultured 
cells metabolically labelled with [35S]- methionine / cystein for 1h. During the chase period 
from 0.5h up to 4h secreted collagens were extracted from the culture supernatant. Samples 
were separated on a 4.5-15% gradient SDS-PAGE under reducing conditions. MC = 
monocultured MSCs, CC = cocultures. N=2 
C.
+ TGFß-3 - TGFß-3
Day 7 Day 14 Day 21
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On the contrary, mRNA expression of Col2a1 was progressively elevated in both mono- and 
cocultured MSCs similarly cartilage exhibited no influence on gene expression level of 
Col2a1 (Fig. 4B). However, secretion of α1/2 (I) and α1 (II) collagen chains was positively 
affected by cartilage when compared with the monocultured MSCs. Notably, in absence of 
external TGFß-3, neither cartilage nor MSCs secreted detectable amounts of collagen I, 
indicated by the lack of the α2 (I) chain while addition of TGFß-3 induced secretion of 
collagen I (Fig. 4C). To deduce the origin of collagens detected in coculture medium, both 
mono and cocultured MSCs (day 21 in presence of TGFß-3) were metabolically labelled with 
35[S] Met/Cys in a pulse/chase regimen after removal of the cartilage explants. After 1 hour of 
chase newly synthesized collagens were detected in the medium of MSCs which were 
previously cultured as cocultures with a secretion peak at 4 hours of chase. We assume most 
of the collagen constitutes collagen II, because of the poor intensity of the lower α2 (I) chain 
compared to the strong signal of the upper α1 (II) band (Fig. 4D). Minuscule collagen 
secretion in monocultured MSCs corroborated the non-radioactive collagen preparation results 
of day 21 (Fig. 4C and D). These data suggest that the factors derived from cartilage explants 
influence collagen II secretion of MSCs indicating a positive influence on biosynthesis of 
collagen II. 
Compared with freshly isolated chondrocytes undifferentiated MSCs exhibit a very low 
baseline expression of Col10a1 mRNA. Induction of chondrogenic differentiation did not 
alter this expression pattern during the first two weeks of culture. Elevation of Col10a1 
mRNA was observed at the terminal stage of the culture (Day 21 and 28). While relative gene 
expression in the chondrogenic control cultures (+ TGFß-3) increased about 100x on day 28 
gene expression in both, monocultured and cocultured MSCs remained suppressed. 
Interestingly, this strong upregulation of collagen X gene expression in MSCs under the 
influence of external TGFß-3 is profoundly suppressed in the presence of cartilage (Fig. 5A). 
Concurrently, collagen X secretion and biosynthesis was strongly suppressed in the presence 
of cartilage compared to the monocultured MSCs which released high amounts of collagen X 
into the culture supernatant.  Little collagen X was detected in the cellular fraction of 
monocultures, however, none was found in cell layers of cocultured MSCs. (Fig. 5B). To 
exclude protease induced degradation of collagen X in the cell culture supernatant of 
cocultures 14C-labelled collagen X was incubated with the cell culture supernatants of mono- 
and cocultured MSCs from day 21 for 7 hours at 37°C. No proteolytic activity was observed 
in mono- or cocultured MSCs supernatants that generated degradation products of collagen X 
or reduced signal intensity of the bands. Therefore, we exclude protease induced degradation 
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(Fig. 5C) and attribute this strong impact of cartilage derived soluble factors on suppression of 
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Figure 5: Relative gene expression, biosynthesis and secretion of collagen X Relative 
mRNA expression level of Col10a1 is assayed by qRT-PCR employing the ∆∆CT method 
using SYBR I Green dye (A). Calibrator was gene expression of day 0 MSCs which 
constitutes the baseline at 1. Expression level of each gene was compared between coculture 
(dotted bars) and monoculture (white bars). Gene expression of monocultured (black bar) and 
cocultured (mosaic bar) MSCs cultured in chondrogenic medium with addition of 10 ng / ml 
TGFß-3 was determined in parallel. Grey bar indicates relative gene expression level of 
freshly isolated hip articular chondrocytes serving as positive control. Analysis of collagen X 
protein biosynthesis and secretion (B): Collagens were precipitated from the alginate beads 
and culture medium, pepsin digested, separated on a 4.5%-15% gradient SDS-PAGE under 
reduced conditions and stained with Coomassie Blue (a). Collagen X degradation assay: 
(14C)-labelled collagen X, isolated from metabolically labelled chicken chondrocyte cultures, 
was incubated with supernatants from mono- and cocultured MSCs (day 21) (b). MC = 
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Profiling of secreted proteins 
To identify soluble factors which may influence chondrogenic differentiation of MSCs cell 
culture supernatant was hybridized to an antibody array. Evaluation of the array containing 
antibodies to 19 secretory molecules resulted in identification of three molecules which 
exhibited differential secretion pattern dependent on the culture condition and time point of 
analysis. Vascular endothelial growth factor (VEGF-164α), tissue inhibitor of 
metalloproteases (TIMP-1) and monocyte attractant protein (MCP-1, data not shown) were 




Fig. 6. Antibody array based detection of 
secreted proteins at day 1, 7 and 14 of the 
culture Culture supernatants were hybridized to 
nylon membrane based antibody arrays. Positive 
signals for TIMP-1 and VEGF-164α showed 
differential secretion pattern depending on the time 
point and condition of the culture. MC = 









High VEGF secretion signals were observed at the onset of the culture in cocultures and 
cartilage explants which decrease at day 14 in cartilage supernatant. Origin of secreted VEGF 
cannot be attributed solely to cartilage explants because at day 14 VEGF is found mainly in 
the supernatant of cocultured MSCs while secretion is reduced in cartilage explant culture. 
However, the secretion is clearly positively influenced by cartilage in coculture because 
monocultured MSCs secret minuscule amounts of VEGF throughout the whole culture time. 
Highest secretion of TIMP-1 was observed in the cartilage explants with slight decline with 
time, the same was observed in cocultured MSCs. Monocultured MSCs downregulated the 
TIMP-1 secretion to almost negligible amount on day 14. Since cocultures supernatant did not 
contain more TIMP-1 compared with the cartilage explant culture, presumably MSCs and 
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cartilage are collectively responsible for the secretion in the cocultures. Furthermore, based on 
the antibody array results secretion of the following pro-inflammatory cytokines and growth 
factors could be excluded at any stage of the culture. These non-secreted factors included 
CINC-2, CNTF, Fractalkine, GM-CSF, IFN-γ, IL-1α, IL-1β, IL-4, IL-6, IL-10, LIX, Leptin, 
MIP-3α, ß-NGF and TNF-α. 
 
Analysis of secretion pattern of MMP-13 and TIMP-2 by zymography 
Reverse zymography was used to detect TIMP-2 in the culture system. Monocultured MSCs 
did not secrete TIMP-2 at any time point; in contrast secretion of TIMP-2 by cartilage 
explants started at day 7 and remained detectable until the end of the culture period. Initially, 
less TIMP-2 secretion was detected in cocultures when compared with cartilage explant 
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Figure 7. Reverse zymography for TIMP-2 Aliquots of culture supernatants from cells were 
subjected to SDS-PAGE under non-reducing conditions on a 4.5-15% gradient gel containing 
1 % gelatine and 25% conditioned macrophage medium. This reverse zymographic analysis 
was applied for detection of TIMP-2. Ca = monocultured cartilage, MC = monocultured 




Gelatine zymogram results indicated secretion of MMP-13 and MMP-9. From the beginning 
of the culture cartilage and cocultures secreted increasing concentration of pro-MMP-13 
without decline till day 21. In contrast, release of pro-enzyme from monocultured MSCs 
remained largely unchanged during the culture period. Notably, the active form of MMP-13 in 
coculture and cartilage culture became reduced in relation to the strongly increasing pro-form 
(Fig. 8A). In coculture and cartilage culture we have observed an additional gelatinolytic 
activity, which we assume to be pro-MMP-9 according to the molecular weight (black arrow 
in fig. 8A). Western blot analysis of culture supernatants confirmed the identity of MMP-13 in 
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both monocultured cartilage explants and in MSCs (data not shown), while MMP-2 was not 
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Figure 8. Gelatine zymography and western blot analysis of MMP-2 and of MMP-13  
Aliquots of cell culture supernatants were subjected to SDS-PAGE under non-reducing 
conditions on a 4.5-15% gradient gel containing 1 % gelatine. Gelatine zymographic analysis 
of the culture supernatant demonstrates secretion of an approximately 60 kDa sized 
proteolytic activity (pro-MMP-13) and a ca. 90 kDa sized band (presumably pro-MMP-9, 
black arrow) into the culture supernatant (A). Selected supernatant samples of cartilage 
monoculture were subjected to western blotting with antibodies against MMP-2 (a) and 
MMP-13 (b) allowing identification of the gelatine degrading MMP as MMP-13 (B). Ca = 





Paracrine factors released from cartilage exert various catabolic and anabolic effects on 
neighbouring cells and tissues. To identify factors with putative regulatory effect on the 
chondrogenic differentiation cascade, a coculture system between articular cartilage and 
pluripotent undifferentiated MSCs was established. The hypothesis suggested that 
Chapter 4 Effect of cartilage on chondrogenesis  Ahmed 2006 
    
 
 80 
differentiation of chondroprogenitor MSCs into chondrocytes is controlled and affected by 
soluble factors secreted by cartilage.  
In the current culture system where MSCs were kept in alginate stabilized 3D environment  
known to induce chondrogenesis in MSCs, Sox9 gene expression was prematurely up 
regulated which indicates early onset of chondrogenesis (Majumdar et al., 2000). Elevated 
gene expression of Sox9 particular on day 7 under the influence of cartilage suggests 
involvement of chondrocyte released signalling factors in regulation of the chondrogenic 
inducer activity of Sox9. Several signalling pathways are involved in regulating Sox9 and its 
downstream genes during cartilage differentiation. TGFß induces Sox9 gene expression and 
transcriptional activity through Smad3 (Furumatsu et al., 2005) and BMP-2 enhances Sox9 
gene expression level during murine fracture healing (Uusitalo et al., 2001). TGFß, released 
from cartilage explants until day 14, presumably accounts in part for the observed increase in 
Sox9 gene expression. On the other hand, VEGF has been described to suppress Sox9 mRNA 
levels during treatment of chick embryo limb buds (Yin and Pacifici, 2001). In our system 
Sox9 gene expression is reduced below initial levels after day 7. Possibly, high secretion level 
of VEGF from MSCs themselves plus cartilage explants induces this suppression of Sox9 in 
MSCs, thereby counteracting the influence of TGFß. Despite suppression of Sox9 mRNA 
below baseline level, gene expression of Col2a1 remains up regulated. This observation 
indicates that an active Sox9 gene above basal level of un-induced MSCs might not be 
mandatory in later stages of chondrogenic differentiation of MSCs for regulation of 
chondrogenesis associated genes as Col2a1, but is imperative at initiation of culture.  
The most profound effect of cartilage derived factors was observed on suppression of collagen 
X gene expression and protein secretion. MSCs, regardless of the presence of cartilage exhibit 
no collagen X secretion before day 21 corroborated by low gene expression until that time 
point. However, from 21 days on monocultured MSCs release high amounts of collagen X 
into the culture supernatant, while cocultures do not. Suppression of collagen X secretion in 
the presence of cartilage depicts delayed hypertrophy in our coculture model. We suggest that 
cartilage derived soluble factors have the ability to reduce collagen X secretion compared to a 
strongly elevated secretion by monocultured MSCs at that stage of culture. As we did not 
observe collagen X degradation products in culture supernatant we deduce that absence of 
collagen X secretion is due to suppression at the biosynthesis level. This suggestion is 
substantiated by significantly reduced gene expression in cocultured MSCs compared with the 
monocultured MSCs. Secondly; we did not detect collagen X protein in the cellular fraction of 
cocultured MSCs while small amounts were retained in monocultured MSCs.  
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Paracrine factors derived from surrounding chondrocytes and endothelial cells alter 
differentiation status of chondrocytes. Chondrocytes of normal articular cartilage do not 
undergo terminal differentiation whereas growth plate chondrocytes do. Articular 
chondrocytes in osteoarthritic joints however, express markers of terminal differentiation like 
collagen X and Alkaline Phosphatase (AP) (von der et al., 1992). By coculturing articular and 
growth plate chondrocytes Jikko et al. could demonstrate that soluble paracrine factors alone 
are responsible for inhibition of terminal differentiation. Articular chondrocytes were able to 
suppress calcification and AP activity in cocultured growth plate chondrocytes, indicating that 
articular chondrocytes produce factors which inhibit terminal differentiation (Jikko et al., 
1999). Also during endochondral ossification cartilage maturation and conversion of 
hypertrophic cartilage to bone is delayed by paracrine signals derived from 
periosteal/perichondrial tissue or from the cartilage proper itself. Formation of new blood 
vessels and their penetration into hypertrophic cartilage appear to be essential for the 
elimination of this developmental barrier. Consistently with this notion, the terminal 
differentiation barrier in chondrocytes from the caudal part of 17-day old chick embryo 
sternum can be eliminated by coculturing them with endothelial cells in-vitro. The humoral 
activity secreted by endothelial cells consists of proteinases sufficient to break down the 
terminal differentiation barrier inherent to this chondrocyte population (Babarina et al., 2001; 
Bittner et al., 1998; Bohme et al., 1995a). In addition, articular chondrocytes obtained from 
osteoarthritic joints are known to secrete factors which activate pro-MMP-9 derived from 
cocultured macrophages. The stepwise activation process of pro-MMP-9 involves MMP-13, 
secreted from chondrocytes and MT1-MMP, also expressed by chondrocytes which converts 
pro-MMP-13 to its active form (Dreier et al., 2001; Dreier et al., 2004; Knauper et al., 2002).  
TIMP-1, TIMP-2, VEGF-164α and MMP13 were the four prominent secreted molecules 
identified in the supernatant of cocultures and cartilage explants. Except VEGF-164α which 
seems to be mainly secreted by cocultured MSCs at least at the final culture stage, a 
reasonable amount of TIMP-1,-2 and MMP13 is released by differentiated chondrocytes of 
the cartilage explants. We observed a profound increase in pro-MMP-13 secretion in coculture 
and cartilage monocultures during the culture period; however with declining activation 
status.  This effect might be due to a concurrent secretion of TIMP-1 and -2, both known as 
efficient inhibitors of MMP-13 activity (Will et al., 1996; Knauper et al., 1997b; Cowell et al., 
1998).  MMP-13 is known to degrade collagen X (Knauper et al., 1997a) however, lack of 
collagen X in supernatant of cocultured MSCs can not be due to proteolytic activities because 
collagen X degradation products or reduced signal intensities were never detected in the 
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cultures. Additionally, in absence of cartilage MMP-13 activation rate was not higher whereas 
collagen X secretion was profoundly increased. In MMP-13 knockout mice Inada et al. have 
demonstrated a profound enlargement of the anatomic domain where collagen X is expressed 
by hypertrophic growth plate chondrocytes and an increase of collagen X deposition in this 
domain. In addition to proteolytic activity of MMP-13 this protease might exert a yet 
unknown regulatory impact on collagen X biosynthesis (Inada et al., 2004; Stickens et al., 
2004). Therefore, suppression of collagen X gene expression and accordingly biosynthesis in 
cocultures might be also due to a regulatory effect of MMP-13 and not to a proteolytic effect.  
Multiple Cbfa1 consensus binding elements are located in the collagen X promoter region 
(Kim et al., 1999; Zheng et al., 2003). Despite induction of Cbaf1 gene expression early in 
MSCs differentiation pathway (day 1) collagen X expression is not significantly induced 
before day 28 while Cbfa1 gene expression is downregulated after 21 days prior to 
upregulation of the col10a1 gene. Also, relative gene expression of Cbfa1 is not significantly 
influenced by cocultured cartilage in our system during the whole culture period whereas gene 
expression of collagen X is. In case Cbfa1 influences collagen X mRNA level we would not 
expect such a profound difference between cocultured and monocultured MSCs therefore, we 
cannot attribute an influence of this transcription factor on mRNA expression or eventual 
transcription of collagen X.  
Another key player in this system might be VEGF-164α, released by cartilage and cocultured 
MSCs. VEGF as one of the most important mediators of angiogenesis is abundantly expressed 
during embryogenesis but in adults it is only found in restricted tissues and cell types, as in 
osteoarthritic chondrocytes, but not in resting chondrocytes (Pufe et al., 2001; Pfander et al., 
2001). Interestingly, we have detected VEGF-164α in increasing amounts in cocultures and 
cartilage, however, main source seems to be cocultured MSCs. VEGF is known to stimulate 
receptor phosphorylation of its VEGF-receptor 2 (flk-1 /KDR), thereby activating the mitogen 
activated protein kinases ERK/1/2 inducing long-lasting activation of the transcription factor 
AP-1 plus expression of c-fos mRNA in dental pulp cells (Pufe et al., 2004b; Matsushita et al., 
2000). As a consensus site for AP-1, a dimeric transcription factor composed of the two 
oncogenic products jun and fos, has been identified within the promoter of collagen X, VEGF 
binding to its receptor (VEGFR1) might contribute to suppression of gene expression of 
collagen X, while at the same time it is known to induce secretion of MMP-13 (Pufe et al., 
2004a). 
All four members of the TIMP-family function as inhibitors of angiogenesis by blocking 
MMP activity. TIMP-1 and -2, both present in cocultures, presumably account for inhibiting 
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generation of active MMP-13. Besides, TIMPs can exert MMP-independent functions, which 
might be important in our system. TIMP-2 exhibits a growth suppressive activity by 
interacting with the α3ß1 integrin on endothelial cells thereby inhibiting cell proliferation 
(Seo et al., 2003). This shows that in addition to inhibition of MMPs TIMPs also regulate cell 
growth and differentiation. Cell surface binding of TIMP-1 and -4 has been reported, but the 
identification of specific cell surface receptors is missing (Stetler-Stevenson and Seo, 2005). 
Therefore, TIMPs secreted by differentiated chondrocytes and MSCs may act as inducers or 
repressors of specific factors necessary for chondrogenic differentiation of MSCs.  
Two additional molecules are described in literature with collagen X regulatory properties. 
PTH / PTHrP expressed in perichondrium and in resting and proliferating chondrocytes 
during endochondral growth (Lee et al., 1996; Iwamoto et al., 1994) strongly represses 
collagen X biosynthesis in chick embryonic hypertrophic chondrocytes thus inhibits matrix 
mineralization and apoptosis of chondrocytes (Zerega et al., 1999). It has been demonstrated 
that PTH / PTHrP fragments suppress collagen X gene expression in vitro by acting on two 
responsive elements within the promoter (Gebhard et al., 2004; Riemer et al., 2002). The 
second molecule is, osteogenic protein 1 (OP-1 or BMP-7) which belongs to the TGFß super 
family (Kingsley, 1994) can induce collagen X gene expression via a cell type specific 
response element that contains an A/T rich and a MEF-2 like sequence which react with yet 
unidentified nuclear proteins in response to OP-1(Harada et al., 1997).  
In conclusion, we have demonstrated that the coculture system including differentiated 
cartilage tissue and undifferentiated MSCs is suitable for studying paracrine communication 
between both the components. Notably, external growth factors are not necessary for 
induction of chondrogenic marker genes and biosynthesis of the corresponding proteins. 
However, for long term maintenance of the gene expression level growth factors like TGFß 
are required as internal secretion by cartilage ceases from day 14 on. Cartilage derived soluble 
factors are sufficient to induce Sox9 gene expression and suppress collagen X 
expression/secretion. MMP-13 and VEGF may have a regulatory role in collagen X 
expression and secretion. Besides the identified secreted proteins, MMP-13, TIMP-1 and -2 
and VEGF-164α other, yet unidentified signalling molecules surely have an impact on 
regulating and directing the differentiation process of MSCs. It shall be kept in mind that in 
the coculture on one hand cartilage derived factors influence fate of MSCs; on the other hand 
MSCs released molecules might have an impact on cartilage metabolism as well. These 
putative proteins may even abrogate the intrinsic blockade which prevents hypertrophy and 
eventual ossification in articular cartilage. Discovering the mutual paracrine influence of 
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differentiated and undifferentiated cells will have direct consequences on therapeutic use of 
either undifferentiated or ex vivo differentiated MSCs for cartilage replacement. For MSCs 
based cartilage repair, inhibition of hypertrophy and stabilization of the cartilaginous 
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Transcription factor Sox9 designated as master regulator of the chondrocytes lineage regulates 
the whole cascade of chondrogenic differentiation. It is also identified as the first transcription 
factor to be expressed during chondrogenesis. Heterozygous Sox9 knockout mice do not 
survive due to lack of rib cartilage and lung collapse which limits Sox9 functional studies. 
Many unclear aspects related to Sox9 and its downstream differentiation specific pathways 
include Sox9 gene regulation, redundancies among Sox family genes, feedback mechanisms, 
effect of level of Sox9 expression on differentiation stage and direct and indirect impact of 
Sox9 activities etc.  Unavailability of Sox9 homozygous knockout mice due to postnatal 
morbidity calls for new techniques for Sox9 functional analysis. One option for development 
of a suitable model system would be in vitro knockdown of genes by RNA interference 




(RNAi). RNAi is a post-transcriptional RNA mediated gene silencing via small interfering 
RNA (siRNA) or short hairpin loop RNA (shRNA). In this study we have knocked down the 
Sox9 gene in murine fibroblast cell line NIH3T3 by using shRNAs specific for Sox9 
employing a retroviral gene delivery system. After 48 hours of transduction 80% knockdown 
at gene expression level and nearly 100% knockdown at protein level were observed. A 
decrease in gene expression of Sox6 was demonstrated 48 hours after knockdown of Sox9. On 
the contrary, Sox4 and Tbox2 mRNA expression level remained unaffected. This pilot in vitro 
gene silencing study serves as a foundation for research on Sox9 silenced primary 
mesenchymal stem cells to identify hithero unknown signalling factors, redundant genes and 
unidentified genes involved in chondrogenesis.  
 
Key words: rat marrow stromal cells, RNAi, Sox9, chondrogenic differentiation 
 
Introduction 
Several studies carried out in chondrocyte cell lines, mesenchymal stem cells, primary 
chondrocytes and on genes of chicken, mice, rats and human, have identified Sox9 as the key 
player of chondrocyte phenotype induction and maintenance. Expression of most of the 
chondrogenesis associated genes including Col2a1, Col9a2, Col11a2, aggrecan, COMP and 
other Sox-family genes, is suggested to be regulated by Sox9 (Akiyama et al., 2002; de 
Crombrugghe et al., 2001; Chimal-Monroy et al., 2003). Sox9 is expressed in all 
chondroprogenitor cells and also in differentiated chondrocytes. The expression starts in 
chondroprogenitor cells, reaches a peak in resting and proliferating chondrocytes and becomes 
completely absent in hypertrophic chondrocytes. Sox9 expression precedes Col2a1 gene 
expression in developing chondrocytes and it is described that MSCs can not condense in 
absence of Sox9 (Chimal-Monroy et al., 2003). Several other transcription factors of the Sox-
family as Sox4, L-Sox5, Sox6, Sox8, Sox9 and Sox10 are also known to be involved in 
chondrogenesis. L-Sox5 and Sox-6 have redundant functions and have been specifically 
implied to be involved in overt chondrogenic differentiation. L-Sox5 and Sox6 double-null 
mice show virtual absence of cartilage and total arrest of chondrogenic differentiation at the 
stage of mesenchymal condensation. Both of them are suggested to be downstream in the 
Sox9 regulatory pathway. In skeletogenesis down regulation of Sox9 is required for transition 
of proliferating chondrocytes to hypertrophic chondrocytes which ultimately leads to bone 
formation in the process of endochondral ossification. Cbfa1, an integral transcription factor 
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of osteoblast differentiation also appears to be under direct and/ or indirect control of Sox9 
(Akiyama et al., 2002; de Crombrugghe et al., 2001). In short, Sox9 is the primary 
transcription factor involved in chondrocyte differentiation conserved across vertebrates, and 
it actively determines the fate of chondrocyte progenitor cells (Healy et al., 1999; Chimal-
Monroy et al., 2003; Bi et al., 1999; de Crombrugghe et al., 2001). Attempts for Sox9 
conventional genetic studies employing transgenic mice have proven fruitless because of post 
natal fatality of Sox9 heterozygous null mutants leaving no hope for generation of Sox9 null 
homozygous animals. The Sox9 heterozygous mice show malformation of cartilage primordia 
and premature mineralization of bones and other typical signs of the human skeletal 
malformation syndrome campomelic dysplasia (Bi et al., 2001). Therefore, studies to 
understand Sox9 expression and activity in chondrogenesis have been limited to mouse 
embryo chimeras derived from Sox9-/- ES or on conditional inactivation of Sox9 by using 
Cre/loxP recombination system (Bi et al., 1999; Akiyama et al., 2002). In conditional 
knockout study, heterozygous transgenic mice containing loxP flanking sites on exon 2 and 3 
of Sox9 gene, which carry the DNA-binding domain, were mated with Cre-containing mice. 
The resultant Sox9 conditional deletion indicated absolute necessity of Sox9 for overt 
differentiation of chondrocytes (Akiyama et al., 2002). However, the level of Sox9 required 
for regulation of other genes of the chondrogenic cascade is still unresolved. Hence, use of 
new technologies and novel ideas for understanding Sox9 function and mode of action is vital.  
RNA interference is a powerful technique for analysis of loss-of-function phenotype. It 
induces degradation of complementary mRNA by introducing double-stranded (ds) RNA into 
organisms as C.elegans and in eukaryotic cells (Rene F.Ketting et al., 2003). These dsRNAs 
are cleaved into 21-25 nucleotide duplexes of short small interfering RNAs (siRNA) which 
initiate sequence-specific degradation of mRNA by mimicking endogenous microRNA 
(miRNA).Both the endogenous miRNA and exogenous siRNA are taken up by RNA-induced 
silencing complex (RISC) which then attaches to the complementary mRNA resulting in gene 
silencing (McManus and Sharp, 2002). The role of miRNA in animals is still not identified 
however; they have been suggested to be involved in developmental regulation. Studies on 
Arabidopsis indicate transcription factors involved in patterning of development to be the 
targets of miRNA directed endonucleolytic cleavage of mRNA. As most of the miRNA are 
evolutionary conserved from worms to mammals their developmental regulation may have 
been a key on the route to multicellular life (Gregory J.Hannon and and Phillip D.Zamore, 
2003). Short hairpin (sh)RNA based interference is a more stable RNAi approach in which 
~50 bp long RNA hairpins consisting of a stem of 19-26 bp are linked to a small ~6 bp 




terminal loop and ~2 bp 3´-overhangs. Inside the cytoplasm these shRNA are treated as pre-
miRNA by RNaseIII enzyme called Dicer resulting in siRNA/miRNA duplexes (Paddison et 
al., 2002; Cullen, 2006).  
In this study we have employed shRNA designed to specifically and stably knockdown Sox9 
gene expression by inducing RNAi using a retroviral based vector system.  
 
Material and Methods 
Cell Culture 
NIH3T3 fibroblast cells were proliferated in DMEM F-12 with 10% FCS (Invitrogen, UK) 
and 1% Penicillin-Streptomycin (PAA, Germany). Cells were cultured in 6 well plates for 
transduction. Packaging cell line EcoPack2-293 was cultured in 10% FCS containing DMEM 
F-12 with 4mM L-Glutamine, 1% antibiotics and 1mM Sodium Pyruvate (Sigma, USA). For 
long term storage in liquid N2 2x106 cells were suspended in 70% FCS and 10% DMSO in 
DMEM. Trypsin-EDTA (Invitrogen, UK; 0.25% Trypsin and 1mM EDTA) was used to 
detach cells from culture vessels.   
 
Viral vector constructs: 
Three individual shRNAs were selected using algorithm promoted by Clonetech, BD 
Bioscience (Table 1). ~69 basepair hairpin loop containing three shRNA pairs were 
manufactured at MWG, Germany. 100µM of top and bottom strands shRNA were each mixed 
in 1:1 ratio and incubated for 30 sec at 95°C and then annealed for 2 min at sequential 
temperature of 72°C, 37°C and 25°C. The annealed top and bottom strands of each shRNA 
were ligated into a shRNA expression vector (RNAi-ready pSIREN retro Q plasmid 
expression vector system, Clonetech, BD, Bioscience) according to the manufacturer’s 
protocol. Briefly, 0.5µM of annealed shRNA were ligated to 25ng/µl of linearized pSIREN 
vector by 400/µl of T4 DNA ligase in presence of 1.5µl of 10x T4 DNA ligase buffer 
containing 10mg/ml BSA, reaction volume was made up to 15µl with nuclease free H2O. 
After 3 h incubation at RT 2µl of the ligated vector was transformed into 50µl of E.coli K-12 
competent cells (Fusion-Blue competent cells, Clonetech, BD Bioscience ,USA). After 30 
min incubation on ice the K-12 cells were subjected to heat shock for 45 sec  at 42°C in a 
water bath and placed back on ice; 950µl of SOC medium was added and transformation was 
carried out at 37°C for 1 h with shaking at 250 rpm. 50µl of the transformation mix was plated 
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on LB agar plates containing ampicillin and incubated overnight at 37°C. Plasmids were 
isolated by an endotoxin free plasmid extraction kit (NecleoBond Plasmid Maxi EF kit, 
Clonetech, BD Bioscience, USA) from overnight culture of bacterial colonies in 3 ml of liquid 
LB medium at 37°C with shaking. Positive clones were identified by restriction and sequence 
analysis. Restriction with BamHI and EcoRI was carried out at 37°C overnight and the 
restricted plasmids were resolved on a 2% agarose gel. Sequence analysis was carried out at 
GeneArt, Germany. Control vector containing a luciferase shRNA was handled exactly in the 
same way as the Sox9 shRNA containing viral constructs.  
 
Generation of shRNA expressing retrovirus: 
Endotoxin-free positively identified plasmids were transfected into EcoPak 293-2 packaging 
cell line with Lipofectamine2000 (Invitrogen, UK) after 24 h 6µg/ml of puromycine was 
added and transfected colonies were selected for ~9 days based on their puromcyin resistance. 
Each selected clone was transferred to a 25 cm2 flask and cells were passaged twice in 75cm2 
flask to obtain enough plasmid harbouring transfected cells for long term storage and 
transduction experiments. For transduction the culture medium containing shRNA expressing 
virus was collected after 48 h of culture until flasks reached confluence. Virus titre was 
determined as advised by the manufacturer and 105 CFU were used for transduction.  
 
Transduction of target cells: 
15,000 of NIH3T3 cells /well were seeded in proliferation medium on a 6 well plate. After 24 
hours nearly 40% confluent wells were tranduced with 1 ml of fresh filtered (0.45µm filter) 
virus mixed with 1 ml of fresh medium containing 6µg/ml  polybrene (final concentration). 
After 24 h of transduction cells were harvested by trypsin digestion, pooled and used for RNA 
and protein analysis. 
 
RNA Isolation and reverse transcriptase-polymerase chain reaction: 
RNA was isolated by an affinity column chromatography method with Ambion’s 
RNAqueous4-PCR kit according to the manufacturer’s protocol.  For removal of possible 
DNA contamination, isolated RNA was incubated for 1 h at 37°C in 2 units of DNaseI 
enzyme (DNA-free, Ambion, USA). The RiboGreen RNA quantification kit (Molecular 
Probes, Invitrogen, UK) was used for determination of RNA concentration at 585nm 
wavelength. For RNA conversion to cDNA, Invitrogen´s SuperScript II reverse transcriptase 
kit was used with 0.5-1 µg of RNA in 20µl of total reaction volume in presence of 40units/µl 




recombinant ribonuclease inhibitor (RNase OUT®). Reverse transcription was carried out 
with 500µg/ml of Oligo-dT primers, 10mM dNTPs and the 200 units of SuperScriptII enzyme 
in First-Strand Buffer and 0.1M DTT for 50 min at 42°C followed by an extension period of 
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Quantitative PCR 
Absolute and relative qPCR was carried out with SYBR Green Dye I on ABI 7000 Prism 
Sequence detection system (Applied Biosystems, USA) according to manufacturer’s 
instructions. Briefly, 0.2µM of each primer was suspended in SYBR green master mix (AB 
Systems) and the reaction was carried out in 96 well plates with 1µl of cDNA in a 50µl final 
volume. For all primer pairs same amplification parameters were used and repeated for 40 
cycles, denaturation at 95°C for 0.15 min and annealing at 60°C for 1 min. Triplicate values 
from three independent experiments were evaluated and mean relative quantification (RQ) 
value was plotted on a semi-logarithmic graph. RQ values were calculated by the software 
“RQ study application v1.1” (ABI Prism 7000 SDS software v1.1) according to the ∆∆Ct 
method using ß-Actin as endogenous control and vector control as calibrator. For absolute 
quantification a standard curve of serially diluted quantified Sox9 plasmid was plotted and 
sample Ct values were used to determine exact copy numbers of Sox9. Primers were designed 
with either Primer3 or Primer express software supplied by Applied Biosystems and 




Table 2: Primers used for quantitative PCR 
Gene / RefSeq# Amplicon (bp)  Primer (5´ - 3´) 
ß-Actin  104   forward -GTAGCCATCCAGGCTGTGTT-3´ 
NM_031144     reverse -CCCTCATAGATGGGCACAGT-3´ 
Sox4   58   forward -GGCCCATGAACGCCTTTAT-3´ 
XM-344594     reverse -CTGGATGAACGGGATCTTGTC-3´ 
Sox6   51   forward-GAAATCCATGTCCAACCAGGAG-3´ 
XM_215016     reverse -CGGGCCTGCTCTTCATAGTAAG-3´ 
Sox9   140      forward -CTGAAGGGCTACGACTGGAC-3´ 
XM_343981        reverse -TACTGGTCTGCCAGCTTCCT-3´ 
Tbox2   71   forward -GCCCACTCTCCGTT TGTATGAG-3´ 










Western blotting was carried out with a lysate of ~106 cells prepared by suspending the cell 
pellet in 1% NP40 Buffer containing 150mM NaCl, 50mM Tris pH 8.0 and 1:10 protease 
inhibitors (Complete Mini, Roche, Germany) in water. Cells were heated for 5 min at 60°C 
immediately followed by incubation for 10 min at 100°C. Cell debris was precipitated by 
centrifugation at 14000xg for 30 min at 4°C and the concentration of protein containing 
supernatant was determined.  A protein aliquot of 5µg was suspended in equal volume of 
0.1M Tris/HCl buffer (pH 6.8) loading buffer containing 4% SDS, 20% glycerine, 5% ß-
Mercaptoethanol and 0.01% bromophenol blue and subjected to 4.5-15% SDS-
polyacrylamide gel electrophoresis. Proteins were electrotransfered to a nitrocellulose 
membrane for 3 h at 4°C. To reduce unspecific binding the membrane was blocked for 1h in 
blocking buffer (5% dry milk in PBS containing 0.1% Tween 20). Blots were incubated 
overnight with 1:500 diluted polyclonal antibodies against Sox9 (AB5535 Chemicon, USA). 
Detection was performed using horseradish-peroxidase coupled secondary antibodies against 
rabbit (A2074, Sigma, USA; 1:50000). Signals were visualized with ECL reagent (Pierce, 
USA) and the membrane was exposed to autoradiography film (Pierce, USA). For dot blot 
analysis, 5µg of protein was spotted and air dried on a nitrocellulose membrane. After 
blocking for 1h the membrane was incubated overnight with an antibody against  ß-Actin 
(AB978, Chemicon, USA; 1:200) and developed as above.  
 
Statistical Analysis: one way ANOVA and student t test were employed for quantitative PCR 
experiments performed in triplicate. The level of significance was determined by Turkey´s test 
with 2 group comparison. 
 
Results and Discussion: 
Cloning and generation of virus particles: One of the preferred gene delivery systems used 
for mammalian cells is retroviral transduction. High transduction efficiency achieved with 
difficult to transfect primary cells as stem cells parallel to long lasting genetic stability are the 
biggest advantages. The annealed Sox9 shRNAs were subcloned into low copy number RNAi-
ready pSIREN retro Q plasmid expression vector system (BD, Bioscience.) suitable for long 
term studies up to several weeks (Fig 1). 
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Figure 1. RNAi-Ready 
pSIREN-RetroQ vector was 
linearized by BamHI and EcoRI 
digestion and shRNA 
containing BamHI and EcoRI 
overhangs were subsequently 
ligated. The shRNA containing 
vector was transformed into 
competent  K-15 E. coli cells 
and positive clones were 
selected by ampicillin 








This modified retroviral gene expression system is a two face system where the vector itself is 
replication incompetent and contains necessary viral RNA processing elements as the LTR 
promoter, packaging signal (Psi+) and tRNA primer binding site along with bacterial origin of 
replication (ColE1 ori). The structural genes gag-pro-pol required for particle formation and 
replication are integrated in an ecotropic EcoPak-293 packaging cell line. Once the replication 
incompetent shRNA from the vector becomes stably integrated into the packaging cell 
genome, the infectious retroviral particles containing the shRNA are produced. The 
expression vector relies on an U6 promoter to drive the expression of shRNA in mammalian 
cells. 
The retroviral particles produced from the 293 cells were used to infect the murine NIH3T3 
fibroblast cell line to transmit the shRNA. E.coli ampicillin resistance gene is necessary for 
selection and propagation of positive clones in bacteria while puromycin resistance permitted 
selection and enrichment of mammalian cells which had taken up the plasmid. The cloned 
plasmids screened by BamHI and EcoRI double digestion which produced a 6.4 Kb linearized 
vector and 69 bp shRNA (data not shown). Positive colonies were used for DNA sequencing 










Figure 2. Sequence analysis of one of the cloned shRNA (shSox9#2) shows proper alignment 
with the plasmid construct. Arrows show BamHI and EcoRI restriction overhangs integrated 




Transduction and evaluation of the knockdown efficiency  
For the evaluation of transfection efficiency cells were harvested after 48 hours of 
transduction. Readout for all tested parameters was the gene expression level of Sox9 
normalized to endogenous control ß-actin and analysed by quantitative PCR. 80% knockdown 
of Sox9 was observed in comparison with the control cells which were transduced with viral 
particles containing an unrelated luciferase shRNA. Evaluation of the knockdown was 
performed at the protein level with western blot and dot blot analysis. Nearly 100% absence 
of Sox9 protein confirmed the knockdown effect. Housekeeping protein ß-actin remained 
unaffected indicating Sox9 gene silencing to be specific and not due to RNAi provoked 
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Figure 3. Knockdown of Sox9 gene expression performed at mRNA level with qPCR shows 
81% lower Sox9 gene expression in the transduced cells in comparison with the control cells 
harbouring the luciferase shRNA vector (A). Nearly 100% reduction was observed at protein 
level (lane 2) in the shSox9 transduced cells compared with the controls (lane 1), while ß-





Downstream gene expression analysis 
After successful Sox9 knockdown downstream effect of the silencing was analysed on 3 
transcription factors. Among them Sox6 is a known member of  Sox9 regulated chondrogenic 
pathway (Lefebvre et al., 2001), while the role of Sox4 in chondrogenic regulation is not clear 
though it is expressed in respiratory tract of embryonic cartilage (Reppe et al., 2000). The role 
of Tbox2 or Brachyury 2 in chondrogenesis is not evident, however Hoffmann et al suggest its 
gene expression to be independent of Sox9 during the chondrogenic cascade (Hoffmann et al., 
2002). Therefore, we evaluated relative mRNA expression of these three transcription factors 
after 48 hours of Sox9 knockdown and compared it with the expression in control cells.  
The results showed a clear down regulation of Sox6 while Tbox2 (1.4 folds) and Sox4 (1.8 
folds) were increased below significant level and thus appeared relatively unaffected by the 
absence of Sox9 (Fig 4). Down regulation of Sox6 in Sox9 knocked down cells is in consort 
with earlier studies which place Sox6 along with its redundant partner Sox5 into the regulatory 
pathway of Sox9 (Lefebvre et al., 1998). Thus its gene expression level in Sox9-silenced cells 
could be used as an indicator of a successful Sox9 knockdown exerting an overt effect on 
other genes. It was also observed that 48 hours of gene silencing is sufficient to display an 
effect on downstream regulated genes as half life of Sox9 mRNA, like for most of the 
B. 
  ß-Actin 
  Sox9 
56 KDa 
1.      2.    




transcription factors, is relatively short and has been reported to be between 1.2- 2.5 h (Sekiya 









Figure 4. Relative qPCR analysis after 48 hours of Sox9 knockdown shows reduction in Sox6 




Sox4 is known to be expressed in osteoblast cell lines and has been localized to the zone of 
hypertrophic chondrocytes in the growth plates of developing foetal mouse hind limbs. This 
suggests an integral role of Sox4 in maturation of osteoblasts (Reppe et al., 2000). Here we 
indicate for the first time that Sox4 gene expression is not influenced by absence of Sox9. 
Tbox2 is a transcription factor containing a T-box DNA binding domain. This family of 
transcription factors is implicated in regulation of the FGF receptor 3 signalling pathway 
which is involved in induction of chondrogenesis in MSCs. In addition it contains receptors 
which bind to FGFs and TGFß, both of these growth factors are known to influence skeletal 
development. On these grounds Hoffman et al have argued a role for Tbox2 in the 
chondrogenic differentiation pathway independent or even prior to Sox9 (Hoffmann et al., 
2002). Our results are in consort with this study which places Tbox2 not in the Sox9 
regulatory cascade but rather parallel to it.  
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In conclusion, we have successfully silenced chondrogenic master regulator Sox9 in a mouse 
fibroblast cell line by inducing RNAi employing shRNA placed into a retroviral gene delivery 
vector. We could demonstrate effect on Sox6 gene expression level, one of the major 
regulatory transcription factors downstream of Sox9. We also suggest Sox4 and Tbox2 not to 
be directly regulated by Sox9. This study provides a gene silencing system for future studies 
on regulation of chondrogenesis and early stages of osteogenesis. The system was designed to 
knockdown Sox9 in MSCs to study possible redundancies in Sox9 driven chondrogenic gene 
cascade. At a later stage the system is to be adapted to an inducible knockdown system where 
Sox9 gene expression will be knocked down during different stages of chondrogenesis to 
identify the role of Sox9 in maintenance of the chondrogenic phenotype. An inducible in vitro 
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Arguably one of the most challenging complex tissues for regenerative medicine is articular 
cartilage. It’s avascular nature, dense extracellular matrix, few cells, and no known specific 
progenitor cells are but a few issues (Cancedda et al., 2003; Hunziker, 2002). For ex vivo 
cartilage regeneration multipotent adult stromal MSCs are the tool of choice because of their 
in vitro pliability and retention of differentiation potential (Barry, 2003). In addition, for cell 
based cartilage therapy use of MSCs instead of chondrocytes as cell source also avoids donor 
site morbidity (Cancedda et al., 2003). However, production of tissue engineered functional 
cartilage with articular characteristics is still a challenge. To effectively address this problem 
employment of the two elements of tissue engineering, the scaffolding material and the cells, 
are needed to be optimized. Thus, studies aiming at better understanding of the chondrogenic 
differentiation cascade and the molecular regulatory mechanisms are essential.  
This thesis concentrated on external regulation and influence on chondrogenesis in MSCs. 
Indisputable effects of microenvironment on proliferation, growth and differentiation of 
MSCs were the intellectual background. The experimental approach was coculture of different 
cell types to explore the impact of microenvironment on chondrogenically differentiating 
MSCs in vitro. Regulatory effects of both the native and artificial environment were reported 
after analyzing the gene expression and protein translation data. The study was carried out in a 
rat model system which is not well characterized for MSCs based differentiation studies; 
therefore, pre-screening studies were a prerequisite. Often in literature it has been pointed out 
that MSCs change their antigenic profile and subsequently loose plasticity upon in vitro 
expansion (Bianco and Robey, 2001). Thus, prior to differentiation studies, MSCs were 
characterized upon their antigenic profile and CFU-F forming capability in chapter 2. The 
colonogenic cells were expanded and found to be predominantly positive for the known 
positive markers of cells of stromal origin as CD71, CD106, CD49a and D7Fib (Pittenger et 
al., 1999). However magnetic and fluorescence sorting of the cell population also revealed 
presence of 20-30% CD45-positive cells of haematopoietic origin (chapter 2, 3). The 




expanded MSCs were screened for osteo-chondro related basal gene expression and secretion 
profiles of cytokines, growth factors and proteases and the differences among this basal 
profile were compared with that of the differentiated cells. Col1a1 was identified as the most 
highly expressed gene in undifferentiated MSCs which could be used as one of the markers of 
marrow derived MSCs. The high expression of master regulators of chondrogenesis and 
osteogenesis, Sox9 and Cbfa1 respectively, in the un-induced MSCs could be an indicator of 
commitment to differentiation towards osteo-/chondrogenic lineages (Bianco et al., 2001). 
These cells also showed retained osteogenic and chondrogenic potential as demonstrated by 
histology. This comprehensive screening of rat marrow derived MSCs serves as a continual 
reference point for differentiation and gene regulation studies.  
In chapter 3 the effect of bone marrow native environment was determined on 
chondrogenically differentiating MSCs in vitro. Bone marrow microenvironment is a complex 
structure where HSCs are retained until they mature and are released into circulation. The 
structural support to these cells is provided by stroma and stromal cells as MSCs, known to be 
precursors of osteoblasts, chondrocytes, fibroblasts, adipocytes, endothelial cells and 
myocytes (Pittenger et al., 1999). Osteogenesis and heamtopoiesis occurs in close proximity; 
osteoblast progenitors influence haematopoiesis and haematopoietic precursor cells generate 
osteoclasts essential for bone resorption (Begg et al., 1993; Yin and Li, 2006). Therefore, the 
in vitro chondrogenic capacity of the mixed population of MSCs (CD45-negative) and HCs 
(CD45-positive) was compared with that of the pure MSCs population to determine the effect 
of CD45- positive bone marrow cells on CD45-negative stromal cells or MSCs. The gene 
expression analysis revealed an up regulation in mRNA level of chondrogenic marker genes 
as Sox9, col2a1 col10a1 and COMP in the mixed population. The results indicate that CD45-
positive cells may create a microenvironment which helps in promotion of chondrogenesis 
under specified culture conditions and thus support chondrogenesis in MSCs in vitro. Stem 
cells are regulated by environmental signals and intrinsic regulatory mechanisms; this in vitro 
study indicates potential involvement of HSCs/ HCs in regulation of chondrogenesis.  
Chapter 4 dealt with articular cartilage released factors and their putative paracrine effect on 
early and late chondrogenic cascade in MSCs. Articular cartilage is a known paracrine organ 
as it maintains its differentiation status via continual regulation through extracellular signals.  
Here, it was shown that the articular cartilage when cultured in the vicinity of MSCs 
influences chondrogenesis in MSCs. The cartilage explant and MSCs were cocultured in 
absence of external growth factors in chambers separated by a 1µm porous membrane which 
limited the contact to paracrine level. The most curious and exciting discovery was 
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suppression of collagen X expression and release from the MSCs under the influence of 
cartilage. Collagen X is accepted as beacon of hypertrophy (Reddi, 1994; Goldring et al., 
2006) its lack indicates delayed hypertrophy due to signalling factors secreted by cartilage. 
Appearance of collagen X is indicative of progressing endochondral ossification while 
maintenance of stable chondrogenic phenotype requires suppression of collagen X. For MSCs 
based ex vivo regeneration of articular cartilage with sustained phenotype, it is vital to 
understand and control collagen X regulation via extrinsic factors. The identified soluble 
signaling molecules including MMP-13, TIMP-2 and VEGFα are proposed to be partially 
responsible for this delay by effecting the gene regulation and/ or biosynthesis. MMP-13 has a 
dual role during hypertrophy, first is the conventional role of the collagenase involved in 
matrix turnover secondly, it is indicated to be a regulator of collagen X gene expression 
(Inada et al., 2004). VEGFα can also activate collagen X inhibiting DNA binding proteins; 
additionally it indirectly promotes MMP-13. The identified molecules may create a chain of 
events causing overt collagen X suppression. Interestingly expression of Sox9, the main 
transcriptional factor of chondrogenesis, was found to be stimulated by the factors released by 
cartilage tissue. This effect was observed in absence of external growth factors required for 
chondrogenic differentiation in vitro. Most likely growth factor Tgfß-3, secreted by cartilage 
is responsible for this early up regulation. After one week of culture an overall decline in Sox9 
mRNA was observed irrespective of Tgfß-3, however, this decline did not hinder the 
progressive up regulation of pro cartilage structural genes. Sox9 is integral for induction of 
chondrogenic differentiation, however, its role in sustenance of chondrogenic phenotype in 
our system remained ambiguous (Lefebvre and Smits, 2005). To find out true hierarchy of 
Sox9 in chondrogenesis in chapter 5 a method was developed to knock down Sox9 by RNA 
interference. The silencing of Sox9 was successfully established in the NIH3T3 fibroblast cell 
line by shRNA delivered by a retroviral expression system. The initial effect on downstream 
regulatory genes indicated a decline in mRNA of Sox6 while Sox4 and Tbox2 remained 
uninfluenced. The establishment of this system proves that the major chondrogenesis 
regulator transcription factor Sox9 could be knocked down in cell culture. The importance of 
this system is reflected by the fact that Sox9 homozygous knockout mouse system is 
unachievable due to prenatal mortality (Akiyama et al., 2002). Studies have also indicated that 
over-expression of Sox9 does not directly relate to over induction of chondrogenesis, therefore 
involvement of other signalling molecules is likely (Furumatsu et al., 2005). This knockdown 
system will be of valuable help in future to identify direct and indirect role of Sox9 in 
chondrogenic regulation. 




In conclusion, this study on paracrine effects of microenvironment during MSCs commitment 
and differentiation demonstrated that the chondrogenic differentiation pathway of rat bone 
marrow derived MSCs is influenced by the microenvironment (Fig 1). The observation of the 
paracrine effect of cartilage tissue on collagen X is a foundation for future studies on the 
identified soluble factors to discover a direct correlation between the effect and the putative 
effectors. The presented paracrine coculture system between cartilage and MSCs and the 
coculture of different bone marrow populations could be used for gene and protein regulation 
studies in future. Identification of signalling molecules responsible for cell fate determination 





Figure 1: ‘Influencing chondrogenesis’ in a nutshell: A summarized schematic diagram of 
main results acquired during this study shows chondrogenic differentiation of rat bone 
marrow derived MSCs upon suspension in alginate and culture in defined chondrogenic 
medium (A) (Chapters 2 and 3). The up regulatory effect of CD45-positive cells on 
chondrogenic differentiation of MSCs (B) (Chapter 3). Early induction and delayed 
hypertrophy induced on differentiating MSCs via soluble factors secreted by cartilage tissue 
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Abstract 
Cartilage damaging injuries or degenerative diseases like osteoarthritis are restrictive and 
painful for normal mobility. Damaged articular cartilage has limited regeneration capacity 
mainly due to lack of chondroprogenitor cells. Chondrocytes are the only cell type of cartilage 
and pluripotent mesenchymal stem cells (MSCs) are the only known adult chondrocyte 
progenitor cells. MSCs have shown promise for tissue engineered therapeutic approach for 
focal defects in articular cartilage. However, production of functional cartilage with articular 
characteristics is still a challenge. Therefore, it is important to identify the molecular events 
and regulatory mechanisms characterizing chondrogenesis in MSCs.  
This thesis has addressed external regulation of chondrogenesis in MSCs. Paracrine signaling 
factors from the surrounding cells are known to modulate differentiation and proliferation in 
surrounding cells, thus, the impact of native and acquired microenvironment on 
differentiation of MSCs was investigated in vitro. Two interesting observations concerning 
chondrogenesis were reported. Firstly the major population of bone marrow the 
haematopoietic cells support chondrogenesis in MSCs in vitro. Gene expression of all the 
chondrogenesis related genes was found to be many folds increased when the MSCs were 
cocultured with 20-30% CD45-positive haematopoietic cells. Secondly we found out that 
articular cartilage when cultured in the vicinity of MSCs also exerts affect on chondrogenesis 
in MSCs. Both of the findings indicate that signaling molecules originating from 
differentiated cells influence chondrogenesis. We also identified some of the soluble signaling 
molecules including MMP-13 TIMP-1, TIMP-2, Tgfß-3 and VEGFα. Interestingly Sox9, the 
main transcriptional factor of chondrogenesis, was found to be stimulated by factors released 
from cartilage. The most curious observation was suppression of collagen X secretion from 
MSCs under the influence of cartilage. The identified soluble molecules like MMP-13, 
VEGFA and TIMP-2 may have a role to play in suppression of collagen X while Tgfß-3 can 
be cause of induction of Sox9. 
The presented paracrine coculture system between cartilage and MSCs and the coculture of 
different bone marrow populations could be used for gene and protein regulation studies in 
future. Identification of signalling molecules responsible for cell fate determination and 
molecular control are empirical for cartilage regenerative medicine. 
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Zusammenfassung 
Degenerative Erkrankungen des Knorpels wie Osteoarthritis oder Verletzungen im Gelenk 
sind sehr schmerzhaft und schränken die normale Beweglichkeit und Lebensqualität ein. Die 
natürliche Regenerationskapazität geschädigten Gelenkknorpels ist jedoch aufgrund des 
Mangels an Knorpelvorläuferzellen stark eingeschränkt. Knorpel wird nur von Chondrozyten 
aufgebaut und pluripotente mesenchymale Stammzellen (MSCs) sind die einzigen bekannten 
adulten Vorläuferzellen von Chondrozyten. MSCs bilden einen vielversprechenden 
therapeutischen Ansatz um mit Hilfe des Tissue Engineering Defekte im artikulären Knorpel 
zu behandeln. Es stellt jedoch eine große Herausforderung dar, funktionellen Knorpel mit 
artikulärer Charakteristik herzustellen. Deshalb ist es von großer Bedeutung, Abläufe auf 
molekularer Ebene und Regulationsmechanismen der Chondrogenese zu identifizieren.  
Diese Arbeit beschäftigt sich mit der externen Reglulation der Chondrogenese in MSCs. Es ist 
bekannt, dass parakrine Faktoren der umgebenden Zellen die Differenzierung beeinflussen; 
darum wurde die Rolle von nativem Knorpel und dessen Mikoumgebung in der 
Differenzierung von MSCs in vitro untersucht. Dabei wurden zwei interessante 
Beobachtungen gemacht: 1. Den Großteil der Zellpopulation des Knochenmarks bilden 
hämatopoetische Zellen welche die Chondrogenese in MSCs in vitro unterstützen. Die 
Expression aller Gene, die in Zusammenhang mit der Chrondrogenese stehen, wurde durch 
die Kokultur mit 20-30% CD45-positiven hämatopoetischen Zellen  um ein vielfaches erhöht.   
2. Ausserdem fanden wir heraus, dass artikulärer Knorpel in Kokultur mit MSCs einen 
positiven Effekt auf die Chondrogenese der MSCs ausübt. Diese beiden Resultate zeigen, dass 
Faktoren, die von differenzierten Zellen stammen, auf die Chondrogenese Einfluss nehmen. 
Wir konnten des Weiteren einige lösliche Signalmoleküle identifizieren wie z.B. MMP-13, 
TIMP-1, TIMP-2, Tgfß-3 and VEGFα. Interessanterweise wird Sox9, der wichtigste 
Transkriptionsfaktor der Chondrogenese durch von Knorpel sezernierte Faktoren stimuliert. 
Eine aussergewöhnliche Beobachtung war, dass in der Anwesenheit von Knorpel die 
Kollagen X Sekretion durch MSCs unterdrückt wurde. Die löslichen Faktoren wie MMP-13, 
VEGFα und TIMP-2 spielen möglicherweise eine Rolle in der Suppression von Kollagen X, 
während Tgfß-3 Sox9 induzieren kann. 
Das dargestellte parakrine Kokulturmodell zwischen Knorpel und MSCs und der Kokultur 
verschiedener Knochenmarks-Zellpopulationen kann in der Zukunft für Gen- und Protein-
Regulationsstudien verwendet werden. 
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